<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Obes Rep</journal-id><journal-id journal-id-type="iso-abbrev">Curr Obes Rep</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Current Obesity Reports</journal-title></journal-title-group><issn pub-type="epub">2162-4968</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10933144</article-id><article-id pub-id-type="pmcid-ver">PMC10933144.1</article-id><article-id pub-id-type="pmcaid">10933144</article-id><article-id pub-id-type="pmcaiid">10933144</article-id><article-id pub-id-type="pmid">38172481</article-id><article-id pub-id-type="doi">10.1007/s13679-023-00544-x</article-id><article-id pub-id-type="publisher-id">544</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Prenatal Exposure to Cannabis: Effects on Childhood Obesity and Cardiometabolic Health</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Moore</surname><given-names initials="BF">Brianna F.</given-names></name><address><email>brianna.f.moore@cuanschutz.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/005x9g035</institution-id><institution-id institution-id-type="GRID">grid.414594.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0401 9614</institution-id><institution>Department of Epidemiology, </institution><institution>Colorado School of Public Health, </institution></institution-wrap>Aurora, CO USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03wmf1y16</institution-id><institution-id institution-id-type="GRID">grid.430503.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0703 675X</institution-id><institution>Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, </institution><institution>University of Colorado Anschutz Medical Campus, </institution></institution-wrap>1890 N Revere Ct, Aurora, 80045 CO USA </aff></contrib-group><pub-date pub-type="epub"><day>3</day><month>1</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2024</year></pub-date><volume>13</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">457756</issue-id><fpage>154</fpage><lpage>166</lpage><history><date date-type="accepted"><day>21</day><month>11</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>01</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>14</day><month>03</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-31 15:25:37.177"><day>31</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="13679_2023_Article_544.pdf"/><abstract id="Abs1"><sec><title>Purpose of Review</title><p id="Par1">To consolidate information on the obesogenic and cardiometabolic effects of prenatal exposure to cannabis.</p></sec><sec><title>Recent Findings</title><p id="Par2">A PubMed search strategy updated from January 1, 2014, through 14 June 2023, produced a total of 47 epidemiologic studies and 12 animal studies. Prenatal exposure to cannabis is consistently associated with small for gestational age and low birth weight. After birth, these offspring gain weight rapidly and have increased adiposity and higher glucose (fat mass percentage) in childhood. More preclinical and prospective studies are needed to deepen our understanding of whether these associations vary by sex, dose, timing, and composition of cannabis (e.g., ratio of delta-&#916;9-tetrahydrocannabinol [&#916;9-THC] to cannabidiol [CBD]). Addressing these gaps may help to solidify causality and identify intervention strategies.</p></sec><sec><title>Summary</title><p id="Par3">Based on the available data, clinicians and public health officials should continue to caution against cannabis use during pregnancy to limit its potential obesogenic and adverse cardiometabolic effects on the offspring.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Prenatal</kwd><kwd>Cannabis</kwd><kwd>Weight</kwd><kwd>Obesity</kwd><kwd>Glucose</kwd><kwd>Metabolic</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R00ES028711</award-id><principal-award-recipient><name name-style="western"><surname>Moore</surname><given-names>Brianna F.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Science+Business Media, LLC, part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par4">Amid increasing legality and growing cultural acceptance, cannabis use in pregnancy is becoming increasingly common. Self-reported data from the 2018 National Survey on Drug Use and Health estimate that 3.7% of pregnant people use cannabis [<xref ref-type="bibr" rid="CR1">1</xref>]. The survey data further shows a higher prevalence among pregnant people who were younger (13.1%) [<xref ref-type="bibr" rid="CR1">1</xref>] or with a cognitive disability (13.0%) [<xref ref-type="bibr" rid="CR2">2</xref>] or depression (12.7%) [<xref ref-type="bibr" rid="CR1">1</xref>]. However, these estimates likely suffer from underreporting. In fact, bioanalytic data from urban hospital settings suggest that up to 30% of pregnant people use or are exposed to cannabis [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par5">The reasons for cannabis use vary [<xref ref-type="bibr" rid="CR5">5</xref>]. Pregnant people report using cannabis to manage nausea, to cope with stress or anxiety, and/or for relaxation and enjoyment [<xref ref-type="bibr" rid="CR6">6</xref>]. There are risks to the offspring that should be weighed in the decision to use cannabis during pregnancy. Prenatal exposure to cannabis was associated with adverse birth outcomes, such as lower birth weight, smaller head circumference, lower Apgar scores, and an increased risk for admission to the neonatal intensive care unit (NICU), as well as altered neurobehavioral traits among older child offspring [<xref ref-type="bibr" rid="CR7">7</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par6">More recently, evidence suggests that prenatal exposure to cannabis may predispose the offspring to obesity, altered glucose homeostasis, and impaired cardiac function [<xref ref-type="bibr" rid="CR12">12</xref>], but there is a need to better understand this growing science. Thus, the goals of this review are to (1) establish the obesogenic and cardiometabolic risks of prenatal exposure to cannabis; (2) recontextualize the cannabis-birth weight literature with respect to childhood obesity and metabolic disorders; (3) propose biological mechanisms underlying these associations; (4) compare the effects of common cannabinoids, namely, delta-&#916;9-tetrahydrocannabinol (&#916;9-THC) and cannabidiol (CBD); and (5) highlight critical gaps in knowledge that are needed to infer causality and identify opportunities for intervention.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par7">A PubMed search strategy was updated through 14 June 2023. The search algorithm included all possible combinations of keywords from the following three groups: (1) &#8220;cannabis,&#8221; &#8220;marijuana,&#8221; &#8220;THC,&#8221; or &#8220;CBD&#8221;; and (2) &#8220;pregnancy,&#8221; &#8220;prenatal,&#8221; &#8220;in utero,&#8221; &#8220;fetal,&#8221; &#8220;offspring,&#8221; &#8220;infant&#8221; or &#8220;early life&#8221;; and (3) &#8220;birth outcomes,&#8221; &#8220;birth weight,&#8221; &#8220;weight,&#8221; &#8220;obes*,&#8221; &#8220;body mass index,&#8221; &#8220;fat mass,&#8221; &#8220;adipo*,&#8221; &#8220;glucose,&#8221; &#8220;insulin,&#8221; &#8220;metabolic syndrome,&#8221; &#8220;cardio*,&#8221; &#8220;cardiac,&#8221; &#8220;blood pressure,&#8221; &#8220;cholesterol,&#8221; &#8220;hypertension,&#8221; or &#8220;lipid.&#8221; This review focused on papers published since 2014, given the increasing legality of cannabis for recreational use over the past decade and changes in cannabis potency [<xref ref-type="bibr" rid="CR13">13</xref>].</p></sec><sec id="Sec3"><title>Results</title><p id="Par8">The PubMed search identified 1898 publications. After removing duplicates, 491 unique publications were screened. Of these, 432 were excluded for the following reasons: commentaries or reviews (<italic toggle="yes">n</italic>&#8201;=&#8201;71); neurodevelopment, cognitive, or behavioral outcomes (<italic toggle="yes">n</italic>&#8201;=&#8201;72); other unrelated health outcomes (<italic toggle="yes">n</italic>&#8201;=&#8201;86); studies of hemp oil, synthetic or endogenous cannabinoids, or the endocannabinoid system (<italic toggle="yes">n</italic>&#8201;=&#8201;36); polysubstance use or drugs other than cannabis (<italic toggle="yes">n</italic>&#8201;=&#8201;24); characteristics or reasons for cannabis use (<italic toggle="yes">n</italic>&#8201;=&#8201;43); prevalence studies (<italic toggle="yes">n</italic>&#8201;=&#8201;18); biomarker studies (<italic toggle="yes">n</italic>&#8201;=&#8201;16); cessation or prevention studies (<italic toggle="yes">n</italic>&#8201;=&#8201;9); health policy analyses (<italic toggle="yes">n</italic>&#8201;=&#8201;3); effects of pre-conception cannabis use (<italic toggle="yes">n</italic>&#8201;=&#8201;3); abstracts or reports presenting insufficient data (<italic toggle="yes">n</italic>&#8201;=&#8201;2); and papers focused entirely on unrelated exposures and outcomes (<italic toggle="yes">n</italic>&#8201;=&#8201;50). Thus, 47 epidemiologic studies [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>&#8226;, <xref ref-type="bibr" rid="CR30">30</xref>&#8211;<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR35">35</xref>&#8211;<xref ref-type="bibr" rid="CR58">58</xref>] and 12 animal models [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR66">66</xref>&#8226;, <xref ref-type="bibr" rid="CR67">67</xref>&#8211;<xref ref-type="bibr" rid="CR70">70</xref>] presenting original data met the inclusion criteria for this review.</p><sec id="Sec4"><title>Evidence from Human Studies</title><p id="Par9">Table <xref rid="Tab1" ref-type="table">1</xref> summarizes the 47 human epidemiologic studies [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>&#8226;, <xref ref-type="bibr" rid="CR30">30</xref>&#8211;<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR35">35</xref>&#8211;<xref ref-type="bibr" rid="CR58">58</xref>]. The most common study design was a retrospective medical record review, followed by a prospective cohort study. Cannabis exposure was most often ascertained through self-report (<italic toggle="yes">n</italic>&#8201;=&#8201;22; 47%), though many studies measured &#916;9-THC in maternal urine collected in pregnancy (<italic toggle="yes">n</italic>&#8201;=&#8201;17; 36%). Four studies captured exposure through &#916;9-THC detected in meconium or umbilical cord tissue homogenate collected at delivery (9%). Cannabis use disorder was the primary exposure of interest in three studies (6%). The prevalence of cannabis use or exposure during pregnancy in the absence of other substances ranged from 2.0 to 38.9%. Co-use of cannabis and other drugs of abuse is common. In a case-control study, Kong et al. [<xref ref-type="bibr" rid="CR29">29</xref>&#8226;] reported that co-use of tobacco and cannabis in pregnancy was nearly 41.3%. Three studies estimated that cannabis use among opioid-dependent pregnant people ranged from 9.4% [<xref ref-type="bibr" rid="CR40">40</xref>] to 40.0% [<xref ref-type="bibr" rid="CR36">36</xref>].
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Human studies on prenatal exposure to cannabis and offspring birth weight, postnatal growth, adiposity, and cardiometabolic health</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="MO1" orientation="portrait" xlink:href="13679_2023_544_Tab1a_HTML.jpg"/><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="MO1234" orientation="portrait" xlink:href="13679_2023_544_Tab1b_HTML.jpg"/><table-wrap-foot><p><italic toggle="yes">BMI</italic> body mass index, <italic toggle="yes">CBD</italic> cannabidiol, <italic toggle="yes">FMI</italic> fat mass index, <italic toggle="yes">MoBa</italic> Mother and Child Cohort Study, <italic toggle="yes">PRAMS</italic> Pregnancy Risk Assessment Monitoring System, <italic toggle="yes">RCT</italic> randomized controlled trial, <italic toggle="yes">SCOPE</italic> Screening for Pregnancy Endpoints, <italic toggle="yes">TGs</italic> triglycerides, <italic toggle="yes">THC</italic> &#916;9-tetrahydrocannabinol</p></table-wrap-foot></table-wrap></p><p id="Par10">Forty-four studies examined the associations between prenatal exposure to cannabis and birth weight (as a continuous measure), low birth weight (&lt;&#8201;2500&#160;g), or small for gestational age (SGA;&#8201;&lt;&#8201;10th percentile). Prenatal exposure to cannabis was associated with a 55 to 732&#160;g reduction in birth weight, with most studies (17 out of the 21) showing a statistically significant reduction in birth weight, independent of gestational age and sex. Roca and colleagues [<xref ref-type="bibr" rid="CR38">38</xref>] reported that prenatal exposure to cannabis was associated with a 40&#160;g increase in birth weight among NICU-admitted neonates. However, consistent with findings by Sturrock and colleagues [<xref ref-type="bibr" rid="CR42">42</xref>], they reported that prenatal exposure to cannabis was associated with a lower birth weight percentile. No effect was noted in a retrospective medical record review of opioid-dependent pregnant people [<xref ref-type="bibr" rid="CR36">36</xref>], in a population-based case-control study of stillbirths [<xref ref-type="bibr" rid="CR45">45</xref>], or in a cross-sectional analysis of Pregnancy Risk Assessment Monitoring System (PRAMS) data [<xref ref-type="bibr" rid="CR28">28</xref>].</p><p id="Par11">Prenatal exposure to cannabis was associated with a statistically significant increase in odds of LBW (adjusted odds ratios [aORs] ranging from 0.9 to 3.9; 11 out of 16 studies showing statistical significance) and SGA (aORs ranging from 1.1 to 2.0; 12 of 17 studies showing statistical significance). The effects were generally independent of gestational age, sex, tobacco/substance in pregnancy, and socioeconomic covariates, such as household income or maternal education. However, the potential for confounding remains moderate. Two studies presented unadjusted models [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR36">36</xref>], few studies adjusted for maternal pre-pregnancy body mass index (BMI) or gestational weight gain, and none adjusted for maternal diet in pregnancy.</p><p id="Par12">Only one published study has examined the association between prenatal exposure to cannabis and postnatal growth. Using data from a New York&#8211;based prospective cohort, Kong et al. [<xref ref-type="bibr" rid="CR29">29</xref>&#8226;] reported that co-exposure to tobacco and cannabis was associated with rapid BMI growth from birth through mid-childhood. However, the effects of cannabis could not be isolated from the effects of tobacco. In an unpublished manuscript, I (along with my co-authors) showed that prenatal exposure to cannabis was associated with rapid BMI growth from birth through age 3&#160;years in the Healthy Start study. Together, these studies suggest that cannabis-exposed infants are smaller at birth, grow rapidly in infancy, and exceed the BMI of unexposed offspring by&#8201;~9&#160;months of age. This pattern of growth is often associated with an increased risk for obesity [<xref ref-type="bibr" rid="CR71">71</xref>], metabolic syndrome [<xref ref-type="bibr" rid="CR72">72</xref>], and type 2 diabetes [<xref ref-type="bibr" rid="CR73">73</xref>] later in life.</p><p id="Par13">In the Generation R Study, Cajachagua-Torres and colleagues [<xref ref-type="bibr" rid="CR19">19</xref>&#8226;&#8226;] reported that maternal or paternal self-report of cannabis use during pregnancy was associated with higher triglycerides and BMI among 10-year-old offspring. This finding is supported by the work of Moore et al. [<xref ref-type="bibr" rid="CR34">34</xref>&#8226;&#8226;] and Kong et al. [<xref ref-type="bibr" rid="CR29">29</xref>&#8226;], which reported higher adiposity (fat mass percentage) among &#916;9-THC-exposed children. However, there is some uncertainty around the effects on metabolic outcomes. Cajachagua-Torres and colleagues [<xref ref-type="bibr" rid="CR19">19</xref>&#8226;&#8226;] reported no association with non-fasting glucose. Conversely, Moore and colleagues [<xref ref-type="bibr" rid="CR34">34</xref>&#8226;&#8226;] showed that prenatal exposure to cannabis was associated with increased fasting glucose at age 5&#160;years.</p></sec><sec id="Sec5"><title>Evidence from Animal Studies</title><p id="Par14">Table <xref rid="Tab2" ref-type="table">2</xref> summarizes the 12 animal studies included in this review [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR61">61</xref>&#8211;<xref ref-type="bibr" rid="CR70">70</xref>]. Wistar rats were the most common model, followed by C57BL/6&#160;J mice and Sprague-Dawley rats. All but one study included both sexes in their experiments. The route of exposure varied, with most experiments utilizing intraperitoneal injection or oral administration. Exposure typically occurred between 6 and 22&#160;days gestation, though some studies included exposure during mating and through weaning.
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Animal studies of prenatal exposure to cannabinoids and offspring growth, adiposity, and cardiometabolic health</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="8" rowspan="1"><bold>Birth weight</bold></th></tr><tr><th align="left" colspan="1" rowspan="1"><bold>Reference</bold></th><th align="left" colspan="1" rowspan="1"><bold>Cannabinoid</bold></th><th align="left" colspan="1" rowspan="1"><bold>Model</bold></th><th align="left" colspan="1" rowspan="1"><bold>Administration</bold></th><th align="left" colspan="1" rowspan="1"><bold>Timing</bold></th><th align="left" colspan="1" rowspan="1"><bold>Dose (per day)</bold></th><th align="left" colspan="1" rowspan="1"><bold><italic toggle="yes">N</italic></bold><bold> (exp, con)</bold></th><th align="left" colspan="1" rowspan="1"><bold>Effect</bold></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Benevenuto et al. [<xref ref-type="bibr" rid="CR69">69</xref>]&#160;</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">Balb/C mice</td><td align="left" colspan="1" rowspan="1">Ambient</td><td align="left" colspan="1" rowspan="1">GD 5.5&#8211;17.5</td><td align="left" colspan="1" rowspan="1">5&#160;min of smoke</td><td align="left" colspan="1" rowspan="1">37, 30</td><td align="left" colspan="1" rowspan="1">Lower BW, stronger effects in males</td></tr><tr><td align="left" colspan="1" rowspan="1">Breit et al. [<xref ref-type="bibr" rid="CR59">59</xref>]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">Sprague-Dawley rats</td><td align="left" colspan="1" rowspan="1">Ambient</td><td align="left" colspan="1" rowspan="1">GD 20</td><td align="left" colspan="1" rowspan="1">30&#160;min of smoke</td><td align="left" colspan="1" rowspan="1">13, 13</td><td align="left" colspan="1" rowspan="1">No difference in BW</td></tr><tr><td align="left" colspan="1" rowspan="1">Gillies et al. [<xref ref-type="bibr" rid="CR60">60</xref>&#8226;&#8226;]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">Female Wistar rats</td><td align="left" colspan="1" rowspan="1">Intraperitoneal injection</td><td align="left" colspan="1" rowspan="1">GD 6&#8211;birth</td><td align="left" colspan="1" rowspan="1">3&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">5, 6</td><td align="left" colspan="1" rowspan="1">Females: Lower BW</td></tr><tr><td align="left" colspan="1" rowspan="1">Lallai et al. [<xref ref-type="bibr" rid="CR62">62</xref>]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">Wistar rats</td><td align="left" colspan="1" rowspan="1">Oral administration</td><td align="left" colspan="1" rowspan="1">GD 1&#8211;20</td><td align="left" colspan="1" rowspan="1">5&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">11, 10</td><td align="left" colspan="1" rowspan="1">Lower BW</td></tr><tr><td align="left" colspan="1" rowspan="1">Lee et al. [<xref ref-type="bibr" rid="CR63">63</xref>&#8226;&#8226;]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">Wistar rats</td><td align="left" colspan="1" rowspan="1">Intraperitoneal injection</td><td align="left" colspan="1" rowspan="1">GD 6&#8211;22</td><td align="left" colspan="1" rowspan="1">3&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">8, 8</td><td align="left" colspan="1" rowspan="1">Lower BW, lower heart-to-BW ratio</td></tr><tr><td align="left" colspan="1" rowspan="1">Natale et al. [<xref ref-type="bibr" rid="CR64">64</xref>]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">Wistar rats</td><td align="left" colspan="1" rowspan="1">Intraperitoneal injection</td><td align="left" colspan="1" rowspan="1">GD 6&#8211;22</td><td align="left" colspan="1" rowspan="1">3&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">8, 8</td><td align="left" colspan="1" rowspan="1">Lower BW, lower liver-to-BW ratio</td></tr><tr><td align="left" colspan="1" rowspan="1">Oke et al. [<xref ref-type="bibr" rid="CR65">65</xref>&#8226;&#8226;]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">Wistar rats</td><td align="left" colspan="1" rowspan="1">Intraperitoneal injection</td><td align="left" colspan="1" rowspan="1">ED 6.5&#8211;22</td><td align="left" colspan="1" rowspan="1">3&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">8, 8</td><td align="left" colspan="1" rowspan="1">Lower liver-to-BW ratio</td></tr><tr><td align="left" colspan="1" rowspan="1">Robinson et al. [<xref ref-type="bibr" rid="CR66">66</xref>&#8226;]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">C57BL/6&#160;J mice</td><td align="left" colspan="1" rowspan="1">Oral administration</td><td align="left" colspan="1" rowspan="1">ED 3.5&#8211;12.5/17.5</td><td align="left" colspan="1" rowspan="1">5 or 10&#160;mg/kg</td><td align="left" colspan="1" rowspan="1">36, 31, 35</td><td align="left" colspan="1" rowspan="1">Lower fetal weight at ED 17.5</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="8" rowspan="1"><bold>Postnatal growth and cardiometabolic outcomes</bold></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Asadi et al. [<xref ref-type="bibr" rid="CR68">68</xref>]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">Wistar rats</td><td align="left" colspan="1" rowspan="1">Intraperitoneal injection</td><td align="left" colspan="1" rowspan="1">GD 6&#8211;birth</td><td align="left" colspan="1" rowspan="1">3&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">8, 8</td><td align="left" colspan="1" rowspan="1"><p>Females: Increased glucagon-to-insulin ratio (21&#160;days)</p><p>No difference in glucose or insulin</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Iezzi et al. [<xref ref-type="bibr" rid="CR61">61</xref>]</td><td align="left" colspan="1" rowspan="1">CBD</td><td align="left" colspan="1" rowspan="1">C57BL/6&#160;J mice</td><td align="left" colspan="1" rowspan="1">Subcutaneous injection</td><td align="left" colspan="1" rowspan="1">GD 5&#8211;18</td><td align="left" colspan="1" rowspan="1">3&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">14, 18</td><td align="left" colspan="1" rowspan="1"><p>Males: Higher postnatal weight (10&#8211;22&#160;days)</p><p>Females: No difference in postnatal weight</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Wanner et al. [<xref ref-type="bibr" rid="CR67">67</xref>]</td><td align="left" colspan="1" rowspan="1">CBD</td><td align="left" colspan="1" rowspan="1">Female A<sup>vy</sup> mice</td><td align="left" colspan="1" rowspan="1">Oral administration</td><td align="left" colspan="1" rowspan="1">Mating-weaning</td><td align="left" colspan="1" rowspan="1">20&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">23, 26</td><td align="left" colspan="1" rowspan="1">No difference in postnatal weight (12&#160;weeks)</td></tr><tr><td align="left" colspan="1" rowspan="1">Oke et al. [<xref ref-type="bibr" rid="CR65">65</xref>&#8226;&#8226;]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">Wistar rats</td><td align="left" colspan="1" rowspan="1">Intraperitoneal injection</td><td align="left" colspan="1" rowspan="1">ED 6.5&#8211;22</td><td align="left" colspan="1" rowspan="1">3&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">8, 8</td><td align="left" colspan="1" rowspan="1"><p>Increased adiposity (6&#160;months)</p><p>Males: Higher hepatic triglycerides (6&#160;months)</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Gillies et al. [<xref ref-type="bibr" rid="CR60">60</xref>&#8226;&#8226;]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">Female Wistar rats</td><td align="left" colspan="1" rowspan="1">Intraperitoneal injection</td><td align="left" colspan="1" rowspan="1">GD 6&#8211;birth</td><td align="left" colspan="1" rowspan="1">3&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">5, 6</td><td align="left" colspan="1" rowspan="1"><p>No difference in postnatal weight (12&#160;days, 5&#160;months)</p><p>Females: Glucose intolerance, decreased pancreatic B-cell mass (5&#160;months)</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Lallai et al. [<xref ref-type="bibr" rid="CR62">62</xref>]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">Wistar rats</td><td align="left" colspan="1" rowspan="1">Oral administration</td><td align="left" colspan="1" rowspan="1">GD 1&#8211;20</td><td align="left" colspan="1" rowspan="1">5&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">11, 10</td><td align="left" colspan="1" rowspan="1">No difference in postnatal weight (15&#160;days)</td></tr><tr><td align="left" colspan="1" rowspan="1">Lee et al. [<xref ref-type="bibr" rid="CR63">63</xref>&#8226;&#8226;]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">Wistar rats</td><td align="left" colspan="1" rowspan="1">Intraperitoneal injection</td><td align="left" colspan="1" rowspan="1">GD 6&#8211;22</td><td align="left" colspan="1" rowspan="1">3&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">8, 8</td><td align="left" colspan="1" rowspan="1">Lower stroke volume, lower cardiac output, adverse left ventricular function (3&#160;weeks)</td></tr><tr><td align="left" colspan="1" rowspan="1">Maciel et al. [<xref ref-type="bibr" rid="CR70">70</xref>]</td><td align="left" colspan="1" rowspan="1">THC, CBD</td><td align="left" colspan="1" rowspan="1">CD1 mice</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">3&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">11, 14, 13</td><td align="left" colspan="1" rowspan="1">No difference in weight at 21 or 60&#160;days</td></tr><tr><td align="left" colspan="1" rowspan="1">Robinson et al. [<xref ref-type="bibr" rid="CR66">66</xref>&#8226;]</td><td align="left" colspan="1" rowspan="1">THC</td><td align="left" colspan="1" rowspan="1">C57BL/6&#160;J mice</td><td align="left" colspan="1" rowspan="1">Oral administration</td><td align="left" colspan="1" rowspan="1">ED 3.5&#8211;12.5/17.5</td><td align="left" colspan="1" rowspan="1">5 or 10&#160;mg/Kg</td><td align="left" colspan="1" rowspan="1">36, 31, 35</td><td align="left" colspan="1" rowspan="1">Myocardial hyperplasia, semilunar valve thickening, lower body/heart weight (21&#160;days)</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">BW</italic> birth weight, <italic toggle="yes">ED</italic> embryonic day, <italic toggle="yes">GD</italic> gestational day, <italic toggle="yes">PD</italic> postnatal day</p></table-wrap-foot></table-wrap></p><p id="Par15">The doses administered to the rodents ranged from 2 to 10&#160;mg/Kg of &#916;9-THC per day and 3 to 20&#160;mg/Kg of CBD per day. This dose mimics moderate recreational cannabis use in human adults (13 to 63&#160;ng/mL), which results in a fetal dose between 4 and 287&#160;ng/mL [<xref ref-type="bibr" rid="CR60">60</xref>&#8226;&#8226;].</p><p id="Par16">Seven of the eight animal studies reported lower birth weights among offspring with prenatal exposure to &#916;9-THC. Breit and colleagues [<xref ref-type="bibr" rid="CR59">59</xref>] found no association, though the Sprague-Dawley rats were exposed only once (30&#160;min of cannabis smoke at gestational day 20). This may provide insight about how frequency and dose may influence offspring birth weight and later-life adiposity.</p><p id="Par17">Both &#916;9-THC and CBD appear to impact postnatal growth. Compared to non-exposed offspring, &#916;9-THC-exposed offspring are born smaller, &#8220;catch-up&#8221; in as little as 12&#160;days [<xref ref-type="bibr" rid="CR60">60</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR62">62</xref>], and begin to surpass the size of non-exposed offspring by age 6&#160;months [<xref ref-type="bibr" rid="CR65">65</xref>&#8226;&#8226;]. Prenatal CBD may impact postnatal growth in a sex-specific manner, with males being more susceptible to this environmental insult [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR67">67</xref>], but the evidence is not conclusive [<xref ref-type="bibr" rid="CR70">70</xref>].</p><p id="Par18">Prenatal exposure to &#916;9-THC impacts many aspects of offspring&#8217;s cardiovascular and metabolic health. Robinson and colleagues [<xref ref-type="bibr" rid="CR66">66</xref>&#8226;] demonstrated that C57BL/6&#160;J mice with prenatal exposure to &#916;9-THC had myocardial valve thickening and ventricular septal defect. These structural changes to the fetal heart may have long-lasting impacts on cardiovascular function. Indeed, Lee and colleagues [<xref ref-type="bibr" rid="CR63">63</xref>&#8226;&#8226;] demonstrated that prenatal &#916;9-THC was associated with lower stroke volume and cardiac output. Additional animal studies conducted at the University of Western Ontario revealed that prenatal &#916;9-THC was associated with increased glucose intolerance at age 5&#160;months among female offspring only [<xref ref-type="bibr" rid="CR60">60</xref>&#8226;&#8226;] and higher hepatic triglycerides at age 6&#160;months among male offspring only [<xref ref-type="bibr" rid="CR65">65</xref>&#8226;&#8226;]. Taken together, studies provide some evidence that prenatal exposure to &#916;9-THC may predispose offspring to dyslipidemia and hyperglycemia across the life course.</p></sec></sec><sec id="Sec6"><title>Discussion</title><sec id="Sec7"><title>Biological Mechanisms</title><p id="Par19">An important tenet of the causal inference framework is to establish the biological plausibility of the observed associations. Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref> summarizes the possible biological mechanisms linking prenatal exposure to cannabis with offspring obesity, cardiovascular health, and metabolic disorders.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Potential mechanisms underlying the associations between prenatal exposure to cannabinoids with child obesity and cardiometabolic health. Images were obtained from the free medical site <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://smart.servier.com/">http://smart.servier.com/</ext-link> by Servier licensed under a Creative Commons Attribution 3.0 Unported License</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="13679_2023_544_Fig1_HTML.jpg"/></fig></p><p id="Par20">Preclinical studies show that &#916;9-THC leads to placental insufficiency [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR74">74</xref>], which may hinder fetal growth. When fetal growth restriction is followed by rapid infant growth, the offspring may be predisposed to abdominal obesity, type 2 diabetes, and cardiovascular disease [<xref ref-type="bibr" rid="CR75">75</xref>]. However, Metz and colleagues [<xref ref-type="bibr" rid="CR45">45</xref>] theorized that the adverse birth effects induced by prenatal exposure to cannabis may be independent of abnormal placental pathology. Thus, other mechanisms may be involved.</p><p id="Par21">Fetal programming in mesenchymal stem cells (MSCs) may play an important role in the cannabis-obesity association. Both &#916;9-THC [<xref ref-type="bibr" rid="CR76">76</xref>] and CBD [<xref ref-type="bibr" rid="CR77">77</xref>] promote adipogenesis in human and mouse MSCs via peroxisome proliferator&#8211;activated receptor gamma (PPAR<bold><italic toggle="yes">&#947;</italic></bold>) activation. Excessive adipogenesis of fetal MSCs may contribute to obesity later in life, regardless of offspring birth weight [<xref ref-type="bibr" rid="CR78">78</xref>].</p><p id="Par22">Cannabinoids may alter RNA regulation of dopamine receptor genes, as demonstrated by DiNieri et al. [<xref ref-type="bibr" rid="CR79">79</xref>] and proposed by de Almeida and Devi [<xref ref-type="bibr" rid="CR80">80</xref>]. Dysregulation of this key reward pathway may alter appetite and satiety and contribute to disinhibited eating. Murine models further showed that &#916;9-THC-exposed male, but not female, offspring impacts mesolimbic dopamine function [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. This may explain the sex-specific effects of CBD on postnatal growth, as reported by Iezzi and colleagues [<xref ref-type="bibr" rid="CR61">61</xref>].</p><p id="Par23">The endocannabinoid system may be integral to the development of the pancreas. The endocannabinoid system is a complex signaling pathway involved in brain development [<xref ref-type="bibr" rid="CR83">83</xref>], metabolism [<xref ref-type="bibr" rid="CR84">84</xref>], and glucose homeostasis [<xref ref-type="bibr" rid="CR85">85</xref>]. Cannabinoid type 1 (CB<sub>1</sub>) receptors are abundant in both glucagon-producing &#945;-cells and insulin-producing &#946;-cells [<xref ref-type="bibr" rid="CR86">86</xref>]. In a mouse model, Malenczyk and colleagues [<xref ref-type="bibr" rid="CR87">87</xref>] showed that 2-arachidonoylglycerol (2-AG, an endocannabinoid that is functionally similar to &#916;9-THC) influenced islet morphology by increasing the number of pancreatic &#945;-cells, which would promote glucagon release, oppose insulin action, and increase blood glucose in exposed pups. In a separate mouse model, Gillies and colleagues [<xref ref-type="bibr" rid="CR60">60</xref>&#8226;&#8226;] reported that prenatal exposure to &#916;9-THC was associated with a significant reduction (41%) of pancreatic &#946;-cells and increased glucose intolerance in female Wistar rats at a postnatal age of 5&#160;months. Asadi and colleagues [<xref ref-type="bibr" rid="CR68">68</xref>] provide compelling evidence that prenatal exposure to &#916;9-THC reprograms fetal islet endocrine hormone profile among female rat offspring. Specifically, stathmin-2 (Stmn2) may play a role in regulating offspring glucose through its interaction with glucagon. Taken together, these studies illustrate how prenatal exposure to cannabis may disrupt the balanced molecular control of insulin and glucagon release via the endocannabinoid system.</p></sec><sec id="Sec8"><title>Individual Cannabinoids</title><p id="Par24">Cannabis is a complex mixture of over 100 cannabinoids [<xref ref-type="bibr" rid="CR88">88</xref>]. &#916;9-THC and CBD are the most abundant and most studied cannabinoids. Disentangling the effects of &#916;9-THC and CBD may have important health implications. Over the past two decades, there has been a dramatic shift in the composition of commercial cannabis products. &#916;9-THC potency has increased three-fold, while the concentration of CBD has been halved [<xref ref-type="bibr" rid="CR13">13</xref>]. CBD use is often perceived as safe among pregnant people and even some obstetrics-related medical professionals [<xref ref-type="bibr" rid="CR89">89</xref>], which may explain why one in five pregnant people report CBD use while pregnant [<xref ref-type="bibr" rid="CR90">90</xref>].</p><p id="Par25">While structurally similar, &#916;9-THC and CBD have different molecular targets. As such, they produce distinct and sometimes opposing effects. For instance, &#916;9-THC is widely accepted as orexogenic [<xref ref-type="bibr" rid="CR91">91</xref>], whereas CBD is often associated with reduced appetite and weight loss [<xref ref-type="bibr" rid="CR92">92</xref>]. To date, there is very little published data regarding the metabolic effects of individual cannabinoids. This is almost certainly due to the scheduling status of the drug, which restricts access to cannabis for research purposes. A 1974 randomized controlled trial reported that a single intravenous administration of &#916;9-THC (6&#160;mg) induced glucose intolerance among healthy adult volunteers [<xref ref-type="bibr" rid="CR93">93</xref>]. Case studies from 1969&#8211;1970 further showed that higher doses of &#916;9-THC can lead to glycosuria [<xref ref-type="bibr" rid="CR94">94</xref>] and diabetic ketoacidosis [<xref ref-type="bibr" rid="CR95">95</xref>]. By contrast, a recent clinical trial shows that a 10:1 ratio of CBD to &#916;9-THC (100&#160;&#181;g CBD and 10&#160;&#181;g &#916;9-THC) improves the lipid profile and glycemic control after 8&#160;weeks among patients with type 2 diabetes [<xref ref-type="bibr" rid="CR96">96</xref>]. Several clinical trials are underway examining the metabolic impacts of &#916;9-THC or CBD administration (e.g., <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05322213">NCT05322213</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05618756">NCT05618756</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04114903">NCT04114903</ext-link>), which may further elucidate the metabolic effects of &#916;9-THC and CBD.</p><p id="Par26">Despite this growing body of evidence, it is not clear whether prenatal exposure to &#916;9-THC and CBD would produce similar cardiometabolic effects on the offspring or whether these cannabinoids impose opposite effects, as it does in adult active users. Furthermore, there are other common cannabinoids that may influence glycemic control. For instance, a recent double-blind randomized controlled trial showed that tetrahydrocannabivarin (THCV) decreased fasting plasma glucose and improved pancreatic &#946;-cell function in adult patients with type 2 diabetes [<xref ref-type="bibr" rid="CR97">97</xref>]. Large prospective cohorts with sufficiently large subgroups of offspring with prenatal exposure to &#916;9-THC, CBD, and other common cannabinoids are needed to explore this question more conclusively in humans.</p></sec><sec id="Sec9"><title>Windows of Susceptibility</title><p id="Par27">Timing may be an important factor in the associations between prenatal exposure to cannabis and offspring adiposity and cardiometabolic health. For instance, early gestation exposure may alter pancreatic development [<xref ref-type="bibr" rid="CR87">87</xref>], whereas late gestation exposure, when the majority of fat accretion occurs [<xref ref-type="bibr" rid="CR98">98</xref>], may have a more profound effect on birth weight and child adiposity. Few studies have attempted to examine whether early vs. late gestation exposure impacts offspring birth outcomes. Three epidemiologic studies reported no effect on birth weight or child metabolic health if the mother quit cannabis early in the pregnancy [<xref ref-type="bibr" rid="CR19">19</xref>&#8226;&#8226;, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. A fourth study reported that cannabis use in the first trimester alone was associated with offspring birth weight, though the effects were more severe if cannabis use was sustained throughout the entire pregnancy [<xref ref-type="bibr" rid="CR46">46</xref>]. Given this paucity of data, there remains a need to quantify exposure at multiple time points throughout pregnancy to formally assess trimester-specific effects.</p><p id="Par28">Beyond the prenatal period, pre-conception exposure may predispose offspring to later-life obesity and cardiometabolic disease, but the evidence is inconsistent. Two human epidemiologic studies reported that pre-conception exposure to cannabis was associated with lower birth weight [<xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR100">100</xref>]. This may occur through the disruption of oocyte maturation [<xref ref-type="bibr" rid="CR101">101</xref>] or through epigenetic changes to sperm among paternal cannabis users [<xref ref-type="bibr" rid="CR102">102</xref>]. However, this hypothesis is inconsistent with a preclinical study, which found no effect on birth weight among offspring of male Wistar rats exposed to &#916;9-THC while mating [<xref ref-type="bibr" rid="CR103">103</xref>]. More research is needed to clarify whether the epidemiologic findings are due to pre-conception exposure alone or rather a continuation of cannabis use in early pregnancy.</p><p id="Par29">Childhood exposure to cannabis is also a growing concern. Self-reported data from the 2015 National Survey on Drug Use and Health estimates that 12% of adults with children in the home use cannabis [<xref ref-type="bibr" rid="CR104">104</xref>]. Bioanalytical studies confirm that at least this many children are exposed, though the prevalence may be higher in younger children. Prospective data from a Colorado-based study indicates that 13% of children, aged 5&#160;years, had detectable levels of CBD in urine [<xref ref-type="bibr" rid="CR105">105</xref>]. Cross-sectional data from Denver, CO [<xref ref-type="bibr" rid="CR106">106</xref>] and New York City, NY [<xref ref-type="bibr" rid="CR107">107</xref>] suggest that nearly 20% of children under 3&#160;years of age had detectable &#916;9-THC concentrations in urine. Given the age of these children, it is not clear whether these exposures occur through breast milk (in which &#916;9-THC readily accumulates [<xref ref-type="bibr" rid="CR108">108</xref>]), through dermal exposure (as cannabinoids are known to accumulate on surfaces [<xref ref-type="bibr" rid="CR109">109</xref>] and young children exhibit increased hand-to-mouth activity [<xref ref-type="bibr" rid="CR110">110</xref>]), or through ambient exposure (an important route of exposure given children&#8217;s faster ventilation rates [<xref ref-type="bibr" rid="CR111">111</xref>]).</p></sec><sec id="Sec10"><title>Mode, Dose, and Frequency of Use</title><p id="Par30">Bioavailability varies widely based on the mode of cannabis use. Cannabinoids exhibit similar pharmacokinetics when administered via inhalation or intravenous injection: peak plasma concentrations occur rapidly (under 10&#160;min) [<xref ref-type="bibr" rid="CR112">112</xref>] and bioavailability is moderate (10&#8211;35%) [<xref ref-type="bibr" rid="CR113">113</xref>]. Due to hepatic first-pass metabolism, the bioavailability of orally consumed &#916;9-THC is very poor,&#8201;&lt;&#8201;20% for edible gelatin capsules and as low as 6% for baked goods [<xref ref-type="bibr" rid="CR114">114</xref>]. As such, oral administration results in lower and more erratic plasma concentrations [<xref ref-type="bibr" rid="CR112">112</xref>]. Given that edibles are the second most common mode of administration among pregnant people [<xref ref-type="bibr" rid="CR115">115</xref>], it may be important to consider the mode of use in future studies examining the cardiometabolic effects of prenatal exposure to cannabis.</p><p id="Par31">Few studies have evaluated potential dose-response effects, which represents an important gap in knowledge. Robinson and colleagues [<xref ref-type="bibr" rid="CR66">66</xref>&#8226;] showed clear dose-dependent effects for 5 and 10&#160;mg/kg &#916;9-THC per day. Frequency of use may also impact these associations. Two epidemiologic studies have reported that the cannabis-birth weight association was only evident among frequent users but not among infrequent users (less than once a month) [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]. Additional dose-response studies are needed to identify threshold effects and solidify the casual nature of these associations.</p></sec><sec id="Sec11"><title>Sex-Specific Effects</title><p id="Par32">The published literature provides some evidence of sexually dimorphic associations between prenatal exposure to cannabinoids and offspring cardiometabolic health, though the patterns and mechanisms are not yet clear.</p><p id="Par33">Males appear to be more susceptible to cannabis-induced impacts on growth. In a longitudinal epidemiologic analysis, Massey and colleagues [<xref ref-type="bibr" rid="CR56">56</xref>] reported that prenatal exposure to cannabis was associated with lower birth weight among male offspring, but not female offspring. This observation is supported by the fact that males are generally more susceptible to early-life environmental insults [<xref ref-type="bibr" rid="CR117">117</xref>]. Furthermore, in a mouse model, Benevenuto and colleagues [<xref ref-type="bibr" rid="CR69">69</xref>] showed that prenatal exposure to cannabis smoke was associated with a lower fetal-placental weight ratio in male rat offspring only, which may imply sex-specific placental insufficiency.</p><p id="Par34">Prenatal CBD appears to have little effect on postnatal growth, though there is some indication of a sex-specific effect. Iezzi and colleagues [<xref ref-type="bibr" rid="CR61">61</xref>] reported that male offspring with developmental exposure to CBD had increased postnatal weights, whereas both Iezzi et al. [<xref ref-type="bibr" rid="CR61">61</xref>] and Wanner et al. [<xref ref-type="bibr" rid="CR67">67</xref>] reported no difference in postnatal weight among female offspring, and Maciel et al. [<xref ref-type="bibr" rid="CR70">70</xref>] reported no difference in either sex. Sex-specific weight differences may be due to increased bioaccumulation of CBD among males [<xref ref-type="bibr" rid="CR70">70</xref>] or CBD potentially exaggerating differences in postnatal growth trajectories among boys and girls [<xref ref-type="bibr" rid="CR118">118</xref>].</p><p id="Par35">Prenatal &#916;9-THC has been linked to increased glucose intolerance among female offspring only [<xref ref-type="bibr" rid="CR60">60</xref>&#8226;&#8226;], which may be attributable to sex-specific differences in the development of the endocannabinoid system [<xref ref-type="bibr" rid="CR119">119</xref>] (which plays a key role in metabolism [<xref ref-type="bibr" rid="CR84">84</xref>] and glucose homeostasis [<xref ref-type="bibr" rid="CR85">85</xref>]) or insulin resistance (which tends to be higher in prepubertal girls as compared to prepubertal boys [<xref ref-type="bibr" rid="CR120">120</xref>]). On the other hand, prenatal &#916;9-THC has also been linked to higher hepatic triglycerides among male offspring only [<xref ref-type="bibr" rid="CR65">65</xref>&#8226;&#8226;]. Oke and colleagues [<xref ref-type="bibr" rid="CR65">65</xref>&#8226;&#8226;] further showed that male, but not female, rat offspring exhibit decreased expression of miR-203a-3p and miR-29a/b/c, both involved in mitochondrial homeostasis in the liver. Beyond epigenetic mechanisms, this sexually dimorphic association may be attributed to differences in lipogenesis and lipolysis [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR122">122</xref>].</p><p id="Par36">These observations highlight the need for more animal models and larger epidemiologic studies with robust sample sizes that allow for effect modification by sex, which would help to make stronger inferences about the causal links between prenatal exposure and cannabis and the risk of childhood cardiometabolic health.</p></sec></sec><sec id="Sec12"><title>Conclusions</title><p id="Par37">Cannabis use during pregnancy is on the rise and may soon surpass tobacco use. Between 2002 and 2016, tobacco use during pregnancy decreased by 40%, whereas the prevalence of cannabis use during pregnancy nearly doubled [<xref ref-type="bibr" rid="CR123">123</xref>]. This is concerning, as the consequences of cannabis use during pregnancy mirror that of tobacco use during pregnancy: offspring are more likely to be born small, grow rapidly in infancy, and have a higher risk of obesity later in life. While the literature has rapidly expanded since 2014, key gaps in knowledge remain. More data is needed to understand whether these associations are cannabinoid-, timing-, dose-, or sex-specific, which would help to strengthen the biological plausibility and reinforce the need for cannabis cessation efforts in pregnant populations. For the time being, the current recommendations to limit cannabis use during pregnancy should continue. Healthcare providers should have open discussions with pregnant patients about the potential risks of cannabis use during pregnancy and provide evidence-based recommendations for safer alternatives when possible.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author Contributions</title><p>B.F.M. designed and implemented the study design, wrote the paper, and prepared all tables and figures.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study is funded (R00ES028711).</p></notes><notes><title>Compliance with Ethical Standards</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of Interest</title><p id="Par38">The authors declare no competing interests.</p></notes><notes id="FPar2"><title>Human and Animal Rights and Informed Consent</title><p id="Par39">This article does not contain any studies with human or animal subjects performed by any of the authors.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref-list id="BSec1"><title>Papers of particular interest, published recently, have been highlighted as: &#8226; Of importance &#8226;&#8226; Of major importance</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Goodwin RD, Zhu J, Heisler Z, Metz TD, Wyka K, Wu M, et al. Cannabis use during pregnancy in the United States: the role of depression. Drug Alcohol Depend. 2020;210:107881. 10.1016/j.drugalcdep.2020.107881.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2020.107881</pub-id><pub-id pub-id-type="pmid">32143978</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitsantas</surname><given-names>P</given-names></name><name name-style="western"><surname>Aljoudi</surname><given-names>SM</given-names></name><name name-style="western"><surname>Gimm</surname><given-names>G</given-names></name></person-group><article-title>Marijuana use in pregnant women with disabilities in the United States</article-title><source>Matern Child Health J</source><year>2022</year><volume>26</volume><issue>2</issue><fpage>242</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1007/s10995-021-03348-4</pub-id><pub-id pub-id-type="pmid">34982342</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Jones MJ, Lotfi A, Lin A, Gievers LL, Hendrickson R, Sheridan DC. Prenatal marijuana exposure and neonatal outcomes: a retrospective cohort study. BMJ Open. 2022;12(9):e061167. 10.1136/bmjopen-2022-061167.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2022-061167</pub-id><pub-id pub-id-type="pmcid">PMC9528601</pub-id><pub-id pub-id-type="pmid">36171027</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mark</surname><given-names>K</given-names></name><name name-style="western"><surname>Desai</surname><given-names>A</given-names></name><name name-style="western"><surname>Terplan</surname><given-names>M</given-names></name></person-group><article-title>Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes</article-title><source>Arch Womens Ment Health</source><year>2016</year><volume>19</volume><issue>1</issue><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1007/s00737-015-0529-9</pub-id><pub-id pub-id-type="pmid">25895138</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Volkow</surname><given-names>ND</given-names></name><name name-style="western"><surname>Han</surname><given-names>B</given-names></name><name name-style="western"><surname>Compton</surname><given-names>WM</given-names></name><name name-style="western"><surname>McCance-Katz</surname><given-names>EF</given-names></name></person-group><article-title>Self-reported medical and nonmedical cannabis use among pregnant women in the United States</article-title><source>JAMA</source><year>2019</year><volume>322</volume><issue>2</issue><fpage>167</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1001/jama.2019.7982</pub-id><pub-id pub-id-type="pmid">31211824</pub-id><pub-id pub-id-type="pmcid">PMC6582258</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vanstone</surname><given-names>M</given-names></name><name name-style="western"><surname>Taneja</surname><given-names>S</given-names></name><name name-style="western"><surname>Popoola</surname><given-names>A</given-names></name><name name-style="western"><surname>Panday</surname><given-names>J</given-names></name><name name-style="western"><surname>Greyson</surname><given-names>D</given-names></name><name name-style="western"><surname>Lennox</surname><given-names>R</given-names></name><etal/></person-group><article-title>Reasons for cannabis use during pregnancy and lactation: a qualitative study</article-title><source>CMAJ</source><year>2021</year><volume>193</volume><issue>50</issue><fpage>E1906</fpage><lpage>E1914</lpage><pub-id pub-id-type="doi">10.1503/cmaj.211236</pub-id><pub-id pub-id-type="pmid">34930765</pub-id><pub-id pub-id-type="pmcid">PMC8687504</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marchand</surname><given-names>G</given-names></name><name name-style="western"><surname>Masoud</surname><given-names>AT</given-names></name><name name-style="western"><surname>Govindan</surname><given-names>M</given-names></name><name name-style="western"><surname>Ware</surname><given-names>K</given-names></name><name name-style="western"><surname>King</surname><given-names>A</given-names></name><name name-style="western"><surname>Ruther</surname><given-names>S</given-names></name><name name-style="western"><surname>Brazil</surname><given-names>G</given-names></name><name name-style="western"><surname>Ulibarri</surname><given-names>H</given-names></name><name name-style="western"><surname>Parise</surname><given-names>J</given-names></name><name name-style="western"><surname>Arroyo</surname><given-names>A</given-names></name><name name-style="western"><surname>Coriell</surname><given-names>C</given-names></name><name name-style="western"><surname>Goetz</surname><given-names>S</given-names></name><name name-style="western"><surname>Karrys</surname><given-names>A</given-names></name><name name-style="western"><surname>Sainz</surname><given-names>K</given-names></name></person-group><article-title>Birth outcomes of neonates exposed to marijuana in utero: a systematic review and meta-analysis</article-title><source>JAMA Netw Open</source><year>2022</year><volume>4</volume><issue>5</issue><fpage>e2145653</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.45653</pub-id><pub-id pub-id-type="pmcid">PMC8796018</pub-id><pub-id pub-id-type="pmid">35084479</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conner</surname><given-names>SN</given-names></name><name name-style="western"><surname>Bedell</surname><given-names>V</given-names></name><name name-style="western"><surname>Lipsey</surname><given-names>K</given-names></name><name name-style="western"><surname>Macones</surname><given-names>GA</given-names></name><name name-style="western"><surname>Cahill</surname><given-names>AG</given-names></name><name name-style="western"><surname>Tuuli</surname><given-names>MG</given-names></name></person-group><article-title>Maternal marijuana use and adverse neonatal outcomes: a systematic review and meta-analysis</article-title><source>Obstet Gynecol</source><year>2016</year><volume>128</volume><issue>4</issue><fpage>713</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1097/aog.0000000000001649</pub-id><pub-id pub-id-type="pmid">27607879</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>CS</given-names></name><name name-style="western"><surname>Jew</surname><given-names>CP</given-names></name><name name-style="western"><surname>Lu</surname><given-names>HC</given-names></name></person-group><article-title>Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain</article-title><source>Future Neurol</source><year>2011</year><volume>6</volume><issue>4</issue><fpage>459</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.2217/fnl.11.27</pub-id><pub-id pub-id-type="pmid">22229018</pub-id><pub-id pub-id-type="pmcid">PMC3252200</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grant</surname><given-names>KS</given-names></name><name name-style="western"><surname>Conover</surname><given-names>E</given-names></name><name name-style="western"><surname>Chambers</surname><given-names>CD</given-names></name></person-group><article-title>Update on the developmental consequences of cannabis use during pregnancy and lactation</article-title><source>Birth Defects Research</source><year>2020</year><volume>112</volume><issue>15</issue><fpage>1126</fpage><lpage>1138</lpage><pub-id pub-id-type="doi">10.1002/bdr2.1766</pub-id><pub-id pub-id-type="pmid">32770666</pub-id><pub-id pub-id-type="pmcid">PMC9241438</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warner</surname><given-names>TD</given-names></name><name name-style="western"><surname>Roussos-Ross</surname><given-names>D</given-names></name><name name-style="western"><surname>Behnke</surname><given-names>M</given-names></name></person-group><article-title>It&#8217;s not your mother&#8217;s marijuana: effects on maternal-fetal health and the developing child</article-title><source>Clin Perinatol</source><year>2014</year><volume>41</volume><issue>4</issue><fpage>877</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1016/j.clp.2014.08.009</pub-id><pub-id pub-id-type="pmid">25459779</pub-id><pub-id pub-id-type="pmcid">PMC4254522</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Lee K, Hardy DB. Metabolic consequences of gestational cannabinoid exposure. Int J Mol Sci. 2021 Sep 2;22(17):9528. 10.3390/ijms22179528.&#160;PMID: 34502436; PMCID: PMC8430813.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22179528</pub-id><pub-id pub-id-type="pmcid">PMC8430813</pub-id><pub-id pub-id-type="pmid">34502436</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>ElSohly</surname><given-names>MA</given-names></name><name name-style="western"><surname>Mehmedic</surname><given-names>Z</given-names></name><name name-style="western"><surname>Foster</surname><given-names>S</given-names></name><name name-style="western"><surname>Gon</surname><given-names>C</given-names></name><name name-style="western"><surname>Chandra</surname><given-names>S</given-names></name><name name-style="western"><surname>Church</surname><given-names>JC</given-names></name></person-group><article-title>Changes in cannabis potency over the last 2 decades (1995&#8211;2014): analysis of current data in the United States</article-title><source>Biol Psychiat</source><year>2016</year><volume>79</volume><issue>7</issue><fpage>613</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2016.01.004</pub-id><pub-id pub-id-type="pmid">26903403</pub-id><pub-id pub-id-type="pmcid">PMC4987131</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bailey</surname><given-names>BA</given-names></name><name name-style="western"><surname>Wood</surname><given-names>DL</given-names></name><name name-style="western"><surname>Shah</surname><given-names>D</given-names></name></person-group><article-title>Impact of pregnancy marijuana use on birth outcomes: results from two matched population-based cohorts</article-title><source>J Perinatol</source><year>2020</year><volume>40</volume><issue>10</issue><fpage>1477</fpage><lpage>1482</lpage><pub-id pub-id-type="doi">10.1038/s41372-020-0643-z</pub-id><pub-id pub-id-type="pmid">32139807</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brar</surname><given-names>BK</given-names></name><name name-style="western"><surname>Patil</surname><given-names>PS</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>DN</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>MO</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>JM</given-names></name><name name-style="western"><surname>Doyle</surname><given-names>NM</given-names></name></person-group><article-title>Effect of intrauterine marijuana exposure on fetal growth patterns and placental vascular resistance</article-title><source>J Matern Fetal Neonatal Med</source><year>2021</year><volume>34</volume><issue>20</issue><fpage>3330</fpage><lpage>3334</lpage><pub-id pub-id-type="doi">10.1080/14767058.2019.1683541</pub-id><pub-id pub-id-type="pmid">31711334</pub-id><pub-id pub-id-type="pmcid">PMC12134661</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brik</surname><given-names>M</given-names></name><name name-style="western"><surname>Sandonis</surname><given-names>M</given-names></name><name name-style="western"><surname>Gil</surname><given-names>J</given-names></name><name name-style="western"><surname>Hernandez-Fleury</surname><given-names>A</given-names></name><name name-style="western"><surname>Parram&#243;n-Puig</surname><given-names>G</given-names></name><name name-style="western"><surname>Maiz</surname><given-names>N</given-names></name><etal/></person-group><article-title>Intrauterine cannabis exposure and fetal and maternal blood flow: a case-control study</article-title><source>Acta Obstet Gynecol Scand</source><year>2022</year><volume>101</volume><issue>11</issue><fpage>1207</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1111/aogs.14439</pub-id><pub-id pub-id-type="pmid">36039819</pub-id><pub-id pub-id-type="pmcid">PMC9812101</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Brown SJ, Mensah FK, Kit JA, Stuart-Butler D, Glover K, Leane C, et al. Use of cannabis during pregnancy and birth outcomes in an aboriginal birth cohort: a cross-sectional, population-based study. BMJ Open. 2016;6(2):e010286. 10.1136/bmjopen-2015-010286.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2015-010286</pub-id><pub-id pub-id-type="pmcid">PMC4769386</pub-id><pub-id pub-id-type="pmid">26908527</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruno</surname><given-names>AM</given-names></name><name name-style="western"><surname>Blue</surname><given-names>NR</given-names></name><name name-style="western"><surname>Allshouse</surname><given-names>AA</given-names></name><name name-style="western"><surname>Haas</surname><given-names>DM</given-names></name><name name-style="western"><surname>Shanks</surname><given-names>AL</given-names></name><name name-style="western"><surname>Grobman</surname><given-names>WA</given-names></name><etal/></person-group><article-title>Marijuana use, fetal growth, and uterine artery Dopplers</article-title><source>J Matern Fetal Neonatal Med</source><year>2022</year><volume>35</volume><issue>25</issue><fpage>7717</fpage><lpage>7724</lpage><pub-id pub-id-type="doi">10.1080/14767058.2021.1960973</pub-id><pub-id pub-id-type="pmid">34470115</pub-id><pub-id pub-id-type="pmcid">PMC9080638</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">&#8226;&#8226; Cajachagua-Torres KN, El Marroun H, Reiss IKM, Santos S, Jaddoe VWV. Foetal tobacco and cannabis exposure, body fat and cardio-metabolic health in childhood. Pediatr Obes. 2022;17(3):e12863. 10.1111/ijpo.12863. <bold>This is the first human study to examine the cardiometabolic effects of prenatal exposure to cannabis. Self-reported maternal or paternal cannabis use during pregnancy was associated with higher body mass index (BMI) among the 10-year-old offspring. However, they reported no association with nonfasting glucose or lipids</bold>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ijpo.12863</pub-id><pub-id pub-id-type="pmcid">PMC9285056</pub-id><pub-id pub-id-type="pmid">34674394</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conner</surname><given-names>SN</given-names></name><name name-style="western"><surname>Carter</surname><given-names>EB</given-names></name><name name-style="western"><surname>Tuuli</surname><given-names>MG</given-names></name><name name-style="western"><surname>Macones</surname><given-names>GA</given-names></name><name name-style="western"><surname>Cahill</surname><given-names>AG</given-names></name></person-group><article-title>Maternal marijuana use and neonatal morbidity</article-title><source>Am J Obstet Gynecol</source><year>2015</year><volume>213</volume><issue>3</issue><fpage>422.e1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2015.05.050</pub-id><pub-id pub-id-type="pmid">26026918</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crume</surname><given-names>TL</given-names></name><name name-style="western"><surname>Juhl</surname><given-names>AL</given-names></name><name name-style="western"><surname>Brooks-Russell</surname><given-names>A</given-names></name><name name-style="western"><surname>Hall</surname><given-names>KE</given-names></name><name name-style="western"><surname>Wymore</surname><given-names>E</given-names></name><name name-style="western"><surname>Borgelt</surname><given-names>LM</given-names></name></person-group><article-title>Cannabis use during the perinatal period in a state with legalized recreational and medical marijuana: the association between maternal characteristics, breastfeeding patterns, and neonatal outcomes</article-title><source>J Pediatr</source><year>2018</year><volume>197</volume><fpage>90</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2018.02.005</pub-id><pub-id pub-id-type="pmid">29605394</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gabrhel&#237;k</surname><given-names>R</given-names></name><name name-style="western"><surname>Mahic</surname><given-names>M</given-names></name><name name-style="western"><surname>Lund</surname><given-names>IO</given-names></name><name name-style="western"><surname>Bramness</surname><given-names>J</given-names></name><name name-style="western"><surname>Selmer</surname><given-names>R</given-names></name><name name-style="western"><surname>Skovlund</surname><given-names>E</given-names></name><etal/></person-group><article-title>Cannabis use during pregnancy and risk of adverse birth outcomes: a longitudinal cohort study</article-title><source>Eur Addict Res</source><year>2021</year><volume>27</volume><issue>2</issue><fpage>131</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1159/000510821</pub-id><pub-id pub-id-type="pmid">33040062</pub-id><pub-id pub-id-type="pmcid">PMC8006586</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grzeskowiak</surname><given-names>LE</given-names></name><name name-style="western"><surname>Grieger</surname><given-names>JA</given-names></name><name name-style="western"><surname>Andraweera</surname><given-names>P</given-names></name><name name-style="western"><surname>Knight</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Leemaqz</surname><given-names>S</given-names></name><name name-style="western"><surname>Poston</surname><given-names>L</given-names></name><etal/></person-group><article-title>The deleterious effects of cannabis during pregnancy on neonatal outcomes</article-title><source>Med J Aust</source><year>2020</year><volume>212</volume><issue>11</issue><fpage>519</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.5694/mja2.50624</pub-id><pub-id pub-id-type="pmid">32452049</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>DS</given-names></name><name name-style="western"><surname>Dhanraj</surname><given-names>DN</given-names></name><name name-style="western"><surname>Devaiah</surname><given-names>CG</given-names></name><name name-style="western"><surname>Lambers</surname><given-names>DS</given-names></name></person-group><article-title>Cannabis use based on urine drug screens in pregnancy and its association with infant birth weight</article-title><source>J Addict Med</source><year>2019</year><volume>13</volume><issue>6</issue><fpage>436</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1097/adm.0000000000000516</pub-id><pub-id pub-id-type="pmid">30908346</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janisse</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>BA</given-names></name><name name-style="western"><surname>Ager</surname><given-names>J</given-names></name><name name-style="western"><surname>Sokol</surname><given-names>RJ</given-names></name></person-group><article-title>Alcohol, tobacco, cocaine, and marijuana use: relative contributions to preterm delivery and fetal growth restriction</article-title><source>Subst Abuse</source><year>2014</year><volume>35</volume><issue>1</issue><fpage>60</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1080/08897077.2013.804483</pub-id><pub-id pub-id-type="pmid">24588295</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joseph-Lemon</surname><given-names>L</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>H</given-names></name><name name-style="western"><surname>Verostick</surname><given-names>L</given-names></name><name name-style="western"><surname>Shizuka Oura</surname><given-names>H</given-names></name><name name-style="western"><surname>Jolles</surname><given-names>DR</given-names></name></person-group><article-title>Outcomes of cannabis use during pregnancy within the American Association of Birth Centers Perinatal Data Registry 2007&#8211;2020: opportunities within midwifery-led care</article-title><source>J Perinat Neonatal Nurs</source><year>2022</year><volume>36</volume><issue>3</issue><fpage>264</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1097/jpn.0000000000000668</pub-id><pub-id pub-id-type="pmid">35894723</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kharbanda</surname><given-names>EO</given-names></name><name name-style="western"><surname>Vazquez-Benitez</surname><given-names>G</given-names></name><name name-style="western"><surname>Kunin-Batson</surname><given-names>A</given-names></name><name name-style="western"><surname>Nordin</surname><given-names>JD</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>A</given-names></name><name name-style="western"><surname>Romitti</surname><given-names>PA</given-names></name></person-group><article-title>Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy</article-title><source>J Perinatol</source><year>2020</year><volume>40</volume><issue>3</issue><fpage>473</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1038/s41372-019-0576-6</pub-id><pub-id pub-id-type="pmid">31911642</pub-id><pub-id pub-id-type="pmcid">PMC7047636</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko</surname><given-names>JY</given-names></name><name name-style="western"><surname>Tong</surname><given-names>VT</given-names></name><name name-style="western"><surname>Bombard</surname><given-names>JM</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>DK</given-names></name><name name-style="western"><surname>Davy</surname><given-names>J</given-names></name><name name-style="western"><surname>Perham-Hester</surname><given-names>KA</given-names></name></person-group><article-title>Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: a population-based study</article-title><source>Drug Alcohol Depend</source><year>2018</year><volume>187</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2018.02.017</pub-id><pub-id pub-id-type="pmid">29627409</pub-id><pub-id pub-id-type="pmcid">PMC7479809</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">&#8226; Kong KL, Lee JK, Shisler S, Thanos PK, Huestis MA, Hawk L, et al. Prenatal tobacco and cannabis co-exposure and offspring obesity development from birth to mid-childhood. Pediatr Obes. 2023;18(5):e13010. 10.1111/ijpo.13010. <bold>This epidemiologic study demonstrated that co-exposure to tobacco and cannabis may influence postnatal growth. Girls appeared to be more susceptible than boys. However, the effects of cannabis could not be differentiated from that of tobacco</bold>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ijpo.13010</pub-id><pub-id pub-id-type="pmcid">PMC10288513</pub-id><pub-id pub-id-type="pmid">36734672</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koto</surname><given-names>P</given-names></name><name name-style="western"><surname>Allen</surname><given-names>VM</given-names></name><name name-style="western"><surname>Fahey</surname><given-names>J</given-names></name><name name-style="western"><surname>Kuhle</surname><given-names>S</given-names></name></person-group><article-title>Maternal cannabis use during pregnancy and maternal and neonatal outcomes: a retrospective cohort study</article-title><source>BJOG</source><year>2022</year><volume>129</volume><issue>10</issue><fpage>1687</fpage><lpage>1694</lpage><pub-id pub-id-type="doi">10.1111/1471-0528.17114</pub-id><pub-id pub-id-type="pmid">35118787</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Luke S, Hobbs AJ, Smith M, Riddell C, Murphy P, Agborsangaya C, et al. Cannabis use in pregnancy and maternal and infant outcomes: a Canadian cross-jurisdictional population-based cohort study. PLoS ONE. 2022;17(11):e0276824. 10.1371/journal.pone.0276824.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0276824</pub-id><pub-id pub-id-type="pmcid">PMC9683571</pub-id><pub-id pub-id-type="pmid">36417349</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mark</surname><given-names>K</given-names></name><name name-style="western"><surname>Crimmins</surname><given-names>S</given-names></name></person-group><article-title>Maternal and infant cannabis testing and associated birth outcomes</article-title><source>Arch Gynecol Obstet</source><year>2023</year><pub-id pub-id-type="doi">10.1007/s00404-023-07009-5</pub-id><pub-id pub-id-type="pmid">37166490</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michalski</surname><given-names>CA</given-names></name><name name-style="western"><surname>Hung</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Seeto</surname><given-names>RA</given-names></name><name name-style="western"><surname>Dennis</surname><given-names>CL</given-names></name><name name-style="western"><surname>Brooks</surname><given-names>JD</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>J</given-names></name><etal/></person-group><article-title>Association between maternal cannabis use and birth outcomes: an observational study</article-title><source>BMC Pregnancy Childbirth</source><year>2020</year><volume>20</volume><issue>1</issue><fpage>771</fpage><pub-id pub-id-type="doi">10.1186/s12884-020-03371-3</pub-id><pub-id pub-id-type="pmid">33308186</pub-id><pub-id pub-id-type="pmcid">PMC7731469</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">&#8226;&#8226; Moore BF, Sauder KA, Shapiro ALB, Crume T, Kinney GL, Dabelea D. Fetal Exposure to Cannabis and childhood metabolic outcomes: the Healthy Start Study. J Clin Endocrinol Metab. 2022;107(7):e2862&#8211;9. 10.1210/clinem/dgac101. <bold>This epidemiologic study demonstrated that biomarker-confirmed fetal exposure to cannabis was associated with increased adiposity and fasting glucose levels in early childhood</bold>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/clinem/dgac101</pub-id><pub-id pub-id-type="pmcid">PMC9202691</pub-id><pub-id pub-id-type="pmid">35357471</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>VH</given-names></name><name name-style="western"><surname>Harley</surname><given-names>KG</given-names></name></person-group><article-title>Prenatal cannabis use and infant birth outcomes in the Pregnancy Risk Assessment Monitoring System</article-title><source>J Pediatr</source><year>2022</year><volume>240</volume><fpage>87</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2021.08.088</pub-id><pub-id pub-id-type="pmid">34508747</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Connor</surname><given-names>AB</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>BK</given-names></name><name name-style="western"><surname>O'Brien</surname><given-names>LM</given-names></name></person-group><article-title>Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine</article-title><source>Drug Alcohol Depend</source><year>2017</year><volume>180</volume><fpage>200</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2017.08.012</pub-id><pub-id pub-id-type="pmid">28917206</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paul</surname><given-names>SE</given-names></name><name name-style="western"><surname>Hatoum</surname><given-names>AS</given-names></name><name name-style="western"><surname>Fine</surname><given-names>JD</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>EC</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>I</given-names></name><name name-style="western"><surname>Karcher</surname><given-names>NR</given-names></name><etal/></person-group><article-title>Associations between prenatal cannabis exposure and childhood outcomes: results from the ABCD Study</article-title><source>JAMA Psychiat</source><year>2021</year><volume>78</volume><issue>1</issue><fpage>64</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2020.2902</pub-id><pub-id pub-id-type="pmcid">PMC7512132</pub-id><pub-id pub-id-type="pmid">32965490</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roca</surname><given-names>A</given-names></name><name name-style="western"><surname>Jarque</surname><given-names>P</given-names></name><name name-style="western"><surname>Gomila</surname><given-names>I</given-names></name><name name-style="western"><surname>Marchei</surname><given-names>E</given-names></name><name name-style="western"><surname>Tittarelli</surname><given-names>R</given-names></name><name name-style="western"><surname>Elorza</surname><given-names>M</given-names></name><etal/></person-group><article-title>Clinical features and risk factors associated with prenatal exposure to drugs of abuse</article-title><source>An Pediatr (Engl Ed)</source><year>2021</year><volume>95</volume><issue>5</issue><fpage>307</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/j.anpede.2020.08.013</pub-id><pub-id pub-id-type="pmid">34635463</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>B</given-names></name><name name-style="western"><surname>Liang</surname><given-names>D</given-names></name></person-group><article-title>The associations between prenatal cannabis use disorder and neonatal outcomes</article-title><source>Addiction</source><year>2021</year><volume>116</volume><issue>11</issue><fpage>3069</fpage><lpage>3079</lpage><pub-id pub-id-type="doi">10.1111/add.15467</pub-id><pub-id pub-id-type="pmid">33887075</pub-id><pub-id pub-id-type="pmcid">PMC8492477</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stein</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>CL</given-names></name><name name-style="western"><surname>Diop</surname><given-names>H</given-names></name><name name-style="western"><surname>Wymore</surname><given-names>E</given-names></name></person-group><article-title>The association of concomitant maternal marijuana use on health outcomes for opioid exposed newborns in Massachusetts, 2003&#8211;2009</article-title><source>J Pediatr</source><year>2020</year><volume>218</volume><fpage>238</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2019.10.071</pub-id><pub-id pub-id-type="pmid">31843217</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Straub</surname><given-names>HL</given-names></name><name name-style="western"><surname>Mou</surname><given-names>J</given-names></name><name name-style="western"><surname>Drennan</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Pflugeisen</surname><given-names>BM</given-names></name></person-group><article-title>Maternal marijuana exposure and birth weight: an observational study surrounding recreational marijuana legalization</article-title><source>Am J Perinatol</source><year>2021</year><volume>38</volume><issue>1</issue><fpage>65</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1055/s-0039-1694793</pub-id><pub-id pub-id-type="pmid">31430821</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sturrock</surname><given-names>S</given-names></name><name name-style="western"><surname>Williams</surname><given-names>E</given-names></name><name name-style="western"><surname>Ambulkar</surname><given-names>H</given-names></name><name name-style="western"><surname>Dassios</surname><given-names>T</given-names></name><name name-style="western"><surname>Greenough</surname><given-names>A</given-names></name></person-group><article-title>Maternal smoking and cannabis use during pregnancy and infant outcomes</article-title><source>J Perinat Med</source><year>2020</year><volume>48</volume><issue>2</issue><fpage>168</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1515/jpm-2019-0422</pub-id><pub-id pub-id-type="pmid">31926099</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Umer</surname><given-names>A</given-names></name><name name-style="western"><surname>Watson</surname><given-names>E</given-names></name><name name-style="western"><surname>Lilly</surname><given-names>C</given-names></name><name name-style="western"><surname>Woods</surname><given-names>S</given-names></name><name name-style="western"><surname>Lefeber</surname><given-names>C</given-names></name><name name-style="western"><surname>Breyel</surname><given-names>J</given-names></name><etal/></person-group><article-title>Substance exposure and adverse neonatal outcomes: a population-based cohort study</article-title><source>J Pediatr</source><year>2023</year><volume>256</volume><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2022.11.040</pub-id><pub-id pub-id-type="pmid">36513212</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warshak</surname><given-names>CR</given-names></name><name name-style="western"><surname>Regan</surname><given-names>J</given-names></name><name name-style="western"><surname>Moore</surname><given-names>B</given-names></name><name name-style="western"><surname>Magner</surname><given-names>K</given-names></name><name name-style="western"><surname>Kritzer</surname><given-names>S</given-names></name><name name-style="western"><surname>Van Hook</surname><given-names>J</given-names></name></person-group><article-title>Association between marijuana use and adverse obstetrical and neonatal outcomes</article-title><source>J Perinatol</source><year>2015</year><volume>35</volume><issue>12</issue><fpage>991</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1038/jp.2015.120</pub-id><pub-id pub-id-type="pmid">26401751</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Metz</surname><given-names>TD</given-names></name><name name-style="western"><surname>Allshouse</surname><given-names>AA</given-names></name><name name-style="western"><surname>Pinar</surname><given-names>H</given-names></name><name name-style="western"><surname>Varner</surname><given-names>M</given-names></name><name name-style="western"><surname>Smid</surname><given-names>MC</given-names></name><name name-style="western"><surname>Hogue</surname><given-names>C</given-names></name><etal/></person-group><article-title>Maternal marijuana exposure, feto-placental weight ratio, and placental histology</article-title><source>Am J Perinatol</source><year>2022</year><volume>39</volume><issue>5</issue><fpage>546</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1055/s-0040-1717092</pub-id><pub-id pub-id-type="pmid">32971561</pub-id><pub-id pub-id-type="pmcid">PMC10506868</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Dodge P, Nadolski K, Kopkau H, Zablocki V, Forrestal K, Bailey BA. The impact of timing of in utero marijuana exposure on fetal growth. Front Pediatr. 2023 May 16;11:1103749.&#160;10.3389/fped.2023.1103749. PMID: 37260795; PMCID: PMC10228645.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fped.2023.1103749</pub-id><pub-id pub-id-type="pmcid">PMC10228645</pub-id><pub-id pub-id-type="pmid">37260795</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coleman-Cowger</surname><given-names>VH</given-names></name><name name-style="western"><surname>Oga</surname><given-names>EA</given-names></name><name name-style="western"><surname>Peters</surname><given-names>EN</given-names></name><name name-style="western"><surname>Mark</surname><given-names>K</given-names></name></person-group><article-title>Prevalence and associated birth outcomes of co-use of cannabis and tobacco cigarettes during pregnancy</article-title><source>Neurotoxicol Teratol</source><year>2018</year><volume>68</volume><fpage>84</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.ntt.2018.06.001</pub-id><pub-id pub-id-type="pmid">29883744</pub-id><pub-id pub-id-type="pmcid">PMC6054553</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Haight SC, King BA, Bombard JM, Coy KC, Ferr&#233; CD, Grant AM, et al. Frequency of cannabis use during pregnancy and adverse infant outcomes, by cigarette smoking status - 8 PRAMS states, 2017. Drug Alcohol Depend. 2021;220:108507. 10.1016/j.drugalcdep.2021.108507.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2021.108507</pub-id><pub-id pub-id-type="pmcid">PMC11268433</pub-id><pub-id pub-id-type="pmid">33476951</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">Prewitt KC, Hayer S, Garg B, Benson AE, Hedges MA, Caughey AB, Lo JO. Impact of prenatal cannabis use disorder on perinatal outcomes. J Addict Med.&#160;2023 May-Jun 01;17(3):e192&#8211;e198. 10.1097/ADM.0000000000001123. Epub 2022 Dec 13. PMID: 37267181; PMCID: PMC10248186.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ADM.0000000000001123</pub-id><pub-id pub-id-type="pmcid">PMC10248186</pub-id><pub-id pub-id-type="pmid">37267181</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oni</surname><given-names>HT</given-names></name><name name-style="western"><surname>Buultjens</surname><given-names>M</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>AL</given-names></name><name name-style="western"><surname>Islam</surname><given-names>MM</given-names></name></person-group><article-title>Neonatal outcomes of infants born to pregnant women with substance use disorders: a multilevel analysis of linked data</article-title><source>Subst Use Misuse</source><year>2022</year><volume>57</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1080/10826084.2021.1958851</pub-id><pub-id pub-id-type="pmid">34369268</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luke</surname><given-names>S</given-names></name><name name-style="western"><surname>Hutcheon</surname><given-names>J</given-names></name><name name-style="western"><surname>Kendall</surname><given-names>T</given-names></name></person-group><article-title>Cannabis use in pregnancy in British Columbia and selected birth outcomes</article-title><source>J Obstet Gynaecol Can</source><year>2019</year><volume>41</volume><issue>9</issue><fpage>1311</fpage><lpage>1317</lpage><pub-id pub-id-type="doi">10.1016/j.jogc.2018.11.014</pub-id><pub-id pub-id-type="pmid">30744979</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodriguez</surname><given-names>CE</given-names></name><name name-style="western"><surname>Sheeder</surname><given-names>J</given-names></name><name name-style="western"><surname>Allshouse</surname><given-names>AA</given-names></name><name name-style="western"><surname>Scott</surname><given-names>S</given-names></name><name name-style="western"><surname>Wymore</surname><given-names>E</given-names></name><name name-style="western"><surname>Hopfer</surname><given-names>C</given-names></name><etal/></person-group><article-title>Marijuana use in young mothers and adverse pregnancy outcomes: a retrospective cohort study</article-title><source>BJOG</source><year>2019</year><volume>126</volume><issue>12</issue><fpage>1491</fpage><lpage>1497</lpage><pub-id pub-id-type="doi">10.1111/1471-0528.15885</pub-id><pub-id pub-id-type="pmid">31334907</pub-id><pub-id pub-id-type="pmcid">PMC8051186</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leemaqz</surname><given-names>SY</given-names></name><name name-style="western"><surname>Dekker</surname><given-names>GA</given-names></name><name name-style="western"><surname>McCowan</surname><given-names>LM</given-names></name><name name-style="western"><surname>Kenny</surname><given-names>LC</given-names></name><name name-style="western"><surname>Myers</surname><given-names>JE</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>NA</given-names></name><etal/></person-group><article-title>Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications</article-title><source>Reprod Toxicol</source><year>2016</year><volume>62</volume><fpage>77</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.reprotox.2016.04.021</pub-id><pub-id pub-id-type="pmid">27142189</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dotters-Katz</surname><given-names>SK</given-names></name><name name-style="western"><surname>Smid</surname><given-names>MC</given-names></name><name name-style="western"><surname>Manuck</surname><given-names>TA</given-names></name><name name-style="western"><surname>Metz</surname><given-names>TD</given-names></name></person-group><article-title>Risk of neonatal and childhood morbidity among preterm infants exposed to marijuana</article-title><source>J Matern Fetal Neonatal Med</source><year>2017</year><volume>30</volume><issue>24</issue><fpage>2933</fpage><lpage>2939</lpage><pub-id pub-id-type="doi">10.1080/14767058.2016.1269165</pub-id><pub-id pub-id-type="pmid">27921445</pub-id><pub-id pub-id-type="pmcid">PMC5612850</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="other">Metz TD, Allshouse AA, Hogue CJ, Goldenberg RL, Dudley DJ, Varner MW, et al. Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity. Am J Obstet Gynecol. 2017;217(4):478.e1&#8211;.e8. 10.1016/j.ajog.2017.05.050.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2017.05.050</pub-id><pub-id pub-id-type="pmcid">PMC5614818</pub-id><pub-id pub-id-type="pmid">28578174</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Massey</surname><given-names>SH</given-names></name><name name-style="western"><surname>Mroczek</surname><given-names>DK</given-names></name><name name-style="western"><surname>Reiss</surname><given-names>D</given-names></name><name name-style="western"><surname>Miller</surname><given-names>ES</given-names></name><name name-style="western"><surname>Jakubowski</surname><given-names>JA</given-names></name><name name-style="western"><surname>Graham</surname><given-names>EK</given-names></name><etal/></person-group><article-title>Additive drug-specific and sex-specific risks associated with co-use of marijuana and tobacco during pregnancy: evidence from 3 recent developmental cohorts (2003&#8211;2015)</article-title><source>Neurotoxicol Teratol</source><year>2018</year><volume>68</volume><fpage>97</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.ntt.2018.06.002</pub-id><pub-id pub-id-type="pmid">29886244</pub-id><pub-id pub-id-type="pmcid">PMC6116514</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corsi</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>L</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>D</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>H</given-names></name><name name-style="western"><surname>El-Chaar</surname><given-names>D</given-names></name><name name-style="western"><surname>Hawken</surname><given-names>S</given-names></name><etal/></person-group><article-title>Association between self-reported prenatal cannabis use and maternal, perinatal, and neonatal outcomes</article-title><source>JAMA</source><year>2019</year><volume>322</volume><issue>2</issue><fpage>145</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1001/jama.2019.8734</pub-id><pub-id pub-id-type="pmid">31211826</pub-id><pub-id pub-id-type="pmcid">PMC6582262</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>DS</given-names></name><name name-style="western"><surname>Turner</surname><given-names>EL</given-names></name><name name-style="western"><surname>Chroust</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Duvall</surname><given-names>KL</given-names></name><name name-style="western"><surname>Wood</surname><given-names>DL</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>BA</given-names></name></person-group><article-title>Marijuana use in opioid exposed pregnancy increases risk of preterm birth</article-title><source>J Matern Fetal Neonatal Med</source><year>2022</year><volume>35</volume><issue>25</issue><fpage>8456</fpage><lpage>8461</lpage><pub-id pub-id-type="doi">10.1080/14767058.2021.1980532</pub-id><pub-id pub-id-type="pmid">34582287</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="other">Breit KR, Rodriguez CG, Lei A, Thomas JD. Combined vapor exposure to THC and alcohol in pregnant rats: maternal outcomes and pharmacokinetic effects. Neurotoxicol Teratol. 2020;82:106930. 10.1016/j.ntt.2020.106930.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ntt.2020.106930</pub-id><pub-id pub-id-type="pmcid">PMC8988991</pub-id><pub-id pub-id-type="pmid">33086086</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="other">&#8226;&#8226; Gillies R, Lee K, Vanin S, Laviolette SR, Holloway AC, Arany E, et al. Maternal exposure to &#916;9-tetrahydrocannabinol impairs female offspring glucose homeostasis and endocrine pancreatic development in the rat. Reprod Toxicol. 2020;94:84&#8211;91. 10.1016/j.reprotox.2020.04.070. <bold>In this Wistar rat model, fetal exposure to &#916;9-THC was associated with female-specific impairments in glucose homeostasis. These findings were later supported in human study (see Moore et al. 2022)</bold>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.reprotox.2020.04.070</pub-id><pub-id pub-id-type="pmid">32325173</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iezzi</surname><given-names>D</given-names></name><name name-style="western"><surname>Caceres-Rodriguez</surname><given-names>A</given-names></name><name name-style="western"><surname>Chavis</surname><given-names>P</given-names></name><name name-style="western"><surname>Manzoni</surname><given-names>OJJ</given-names></name></person-group><article-title>In utero exposure to cannabidiol disrupts select early-life behaviors in a sex-specific manner</article-title><source>Transl Psychiatry</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>501</fpage><pub-id pub-id-type="doi">10.1038/s41398-022-02271-8</pub-id><pub-id pub-id-type="pmid">36470874</pub-id><pub-id pub-id-type="pmcid">PMC9722662</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lallai</surname><given-names>V</given-names></name><name name-style="western"><surname>Manca</surname><given-names>L</given-names></name><name name-style="western"><surname>Sherafat</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fowler</surname><given-names>CD</given-names></name></person-group><article-title>Effects of prenatal nicotine, THC, or co-exposure on cognitive behaviors in adolescent male and female rats</article-title><source>Nicotine Tob Res</source><year>2022</year><volume>24</volume><issue>8</issue><fpage>1150</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1093/ntr/ntac018</pub-id><pub-id pub-id-type="pmid">35090174</pub-id><pub-id pub-id-type="pmcid">PMC9278841</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="other">&#8226;&#8226; Lee K, Laviolette SR, Hardy DB. Exposure to &#916;9-tetrahydrocannabinol during rat pregnancy leads to impaired cardiac dysfunction in postnatal life. Pediatr Res. 2021;90(3):532&#8211;9. 10.1038/s41390-021-01511-9. <bold>This study found that prenatal exposure to &#916;9-THC was associated with fetal growth restriction and impaired cardiac function in the Wistar rat offspring</bold>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41390-021-01511-9</pub-id><pub-id pub-id-type="pmcid">PMC8519775</pub-id><pub-id pub-id-type="pmid">33879850</pub-id></mixed-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Natale</surname><given-names>BV</given-names></name><name name-style="western"><surname>Gustin</surname><given-names>KN</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K</given-names></name><name name-style="western"><surname>Holloway</surname><given-names>AC</given-names></name><name name-style="western"><surname>Laviolette</surname><given-names>SR</given-names></name><name name-style="western"><surname>Natale</surname><given-names>DRC</given-names></name><etal/></person-group><article-title>&#916;9-Tetrahydrocannabinol exposure during rat pregnancy leads to symmetrical fetal growth restriction and labyrinth-specific vascular defects in the placenta</article-title><source>Sci Rep</source><year>2020</year><volume>10</volume><issue>1</issue><fpage>544</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-57318-6</pub-id><pub-id pub-id-type="pmid">31953475</pub-id><pub-id pub-id-type="pmcid">PMC6969028</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="other">&#8226;&#8226; Oke SL, Lee K, Papp R, Laviolette SR, Hardy DB. In utero exposure to &#916;9-tetrahydrocannabinol leads to postnatal catch-up growth and dysmetabolism in the adult rat liver. Int J Mol Sci. 2021 Jul 13;22(14):7502. 10.3390/ijms22147502.&#160;PMID: 34299119; PMCID: PMC8305322. <bold>The study demonstrated that prenatal exposure to &#916;9-THC is associated with long-term dyslipidemia and provides evidence for plausible biological mechansims (enhanced hepatic lipogenesis, mitochondrial dysfunction, and epigenetic mechanisms)</bold>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22147502</pub-id><pub-id pub-id-type="pmcid">PMC8305322</pub-id><pub-id pub-id-type="pmid">34299119</pub-id></mixed-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="other">&#8226; Robinson GI, Ye F, Lu X, Laviolette SR, Feng Q. Maternal delta-9-tetrahydrocannabinol exposure induces abnormalities of the developing heart in mice. Cannabis Cannabinoid Res. 2022 Oct 17. 10.1089/can.2022.0180.&#160;Epub ahead of print. PMID: 36255470. <bold>This mouse model demonstrated that prenatal exposure to &#916;9-THC may result in abnormalities in fetal heart development in mice, leading to postnatal cardiac dysfunction. These results are consistent with the work of Lee et al. (2021) and provide a potnetial mechanism for the cannabis-cardiovascular association.</bold><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/can.2022.0180</pub-id><pub-id pub-id-type="pmid">36255470</pub-id></mixed-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wanner</surname><given-names>NM</given-names></name><name name-style="western"><surname>Colwell</surname><given-names>M</given-names></name><name name-style="western"><surname>Drown</surname><given-names>C</given-names></name><name name-style="western"><surname>Faulk</surname><given-names>C</given-names></name></person-group><article-title>Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice</article-title><source>Clin Epigenetics</source><year>2021</year><volume>13</volume><issue>1</issue><fpage>4</fpage><pub-id pub-id-type="doi">10.1186/s13148-020-00993-4</pub-id><pub-id pub-id-type="pmid">33407853</pub-id><pub-id pub-id-type="pmcid">PMC7789000</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asadi</surname><given-names>F</given-names></name><name name-style="western"><surname>Fernandez Andrade</surname><given-names>JA</given-names></name><name name-style="western"><surname>Gillies</surname><given-names>R</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K</given-names></name><name name-style="western"><surname>Dhanvantari</surname><given-names>S</given-names></name><name name-style="western"><surname>Hardy</surname><given-names>DB</given-names></name><etal/></person-group><article-title>Sex-dependent effect of in-utero exposure to &#916;(9-)tetrahydrocannabinol on glucagon and stathmin-2 in adult rat offspring</article-title><source>Can J Diabetes</source><year>2022</year><volume>46</volume><issue>8</issue><fpage>851</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1016/j.jcjd.2022.06.009</pub-id><pub-id pub-id-type="pmid">35985923</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benevenuto</surname><given-names>SG</given-names></name><name name-style="western"><surname>Domenico</surname><given-names>MD</given-names></name><name name-style="western"><surname>Martins</surname><given-names>MAG</given-names></name><name name-style="western"><surname>Costa</surname><given-names>NS</given-names></name><name name-style="western"><surname>de Souza</surname><given-names>ARL</given-names></name><name name-style="western"><surname>Costa</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Recreational use of marijuana during pregnancy and negative gestational and fetal outcomes: an experimental study in mice</article-title><source>Toxicology</source><year>2017</year><volume>376</volume><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2016.05.020</pub-id><pub-id pub-id-type="pmid">27234314</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maciel</surname><given-names>IS</given-names></name><name name-style="western"><surname>Abreu</surname><given-names>GHD</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>CT</given-names></name><name name-style="western"><surname>Bonday</surname><given-names>R</given-names></name><name name-style="western"><surname>Bradshaw</surname><given-names>HB</given-names></name><name name-style="western"><surname>Mackie</surname><given-names>K</given-names></name><etal/></person-group><article-title>Perinatal CBD or THC exposure results in lasting resistance to fluoxetine in the forced swim test: reversal by fatty acid amide hydrolase inhibition</article-title><source>Cannabis Cannabinoid Res</source><year>2022</year><volume>7</volume><issue>3</issue><fpage>318</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1089/can.2021.0015</pub-id><pub-id pub-id-type="pmid">34182795</pub-id><pub-id pub-id-type="pmcid">PMC9225394</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Wit</surname><given-names>CC</given-names></name><name name-style="western"><surname>Sas</surname><given-names>TC</given-names></name><name name-style="western"><surname>Wit</surname><given-names>JM</given-names></name><name name-style="western"><surname>Cutfield</surname><given-names>WS</given-names></name></person-group><article-title>Patterns of catch-up growth</article-title><source>J Pediatr</source><year>2013</year><volume>162</volume><issue>2</issue><fpage>415</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2012.10.014</pub-id><pub-id pub-id-type="pmid">23153864</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cettour-Rose</surname><given-names>P</given-names></name><name name-style="western"><surname>Samec</surname><given-names>S</given-names></name><name name-style="western"><surname>Russell</surname><given-names>AP</given-names></name><name name-style="western"><surname>Summermatter</surname><given-names>S</given-names></name><name name-style="western"><surname>Mainieri</surname><given-names>D</given-names></name><name name-style="western"><surname>Carrillo-Theander</surname><given-names>C</given-names></name><etal/></person-group><article-title>Redistribution of glucose from skeletal muscle to adipose tissue during catch-up fat: a link between catch-up growth and later metabolic syndrome</article-title><source>Diabetes</source><year>2005</year><volume>54</volume><issue>3</issue><fpage>751</fpage><lpage>756</lpage><pub-id pub-id-type="doi">10.2337/diabetes.54.3.751</pub-id><pub-id pub-id-type="pmid">15734852</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barker</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Hales</surname><given-names>CN</given-names></name><name name-style="western"><surname>Fall</surname><given-names>CH</given-names></name><name name-style="western"><surname>Osmond</surname><given-names>C</given-names></name><name name-style="western"><surname>Phipps</surname><given-names>K</given-names></name><name name-style="western"><surname>Clark</surname><given-names>PM</given-names></name></person-group><article-title>Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth</article-title><source>Diabetologia</source><year>1993</year><volume>36</volume><issue>1</issue><fpage>62</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1007/bf00399095</pub-id><pub-id pub-id-type="pmid">8436255</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="other">Chang X, Li H, Li Y, He Q, Yao J, Duan T, et al. RhoA/MLC signaling pathway is involved in &#916;9-tetrahydrocannabinol-impaired placental angiogenesis. Toxicol Lett. 2018;285:148&#8211;55. 10.1016/j.toxlet.2017.12.031.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2017.12.031</pub-id><pub-id pub-id-type="pmid">29307655</pub-id></mixed-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dulloo</surname><given-names>AG</given-names></name></person-group><article-title>Regulation of fat storage via suppressed thermogenesis: a thrifty phenotype that predisposes individuals with catch-up growth to insulin resistance and obesity</article-title><source>Horm Res</source><year>2006</year><volume>65</volume><issue>Suppl 3</issue><fpage>90</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1159/000091512</pub-id><pub-id pub-id-type="pmid">16612120</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teixeira</surname><given-names>D</given-names></name><name name-style="western"><surname>Pestana</surname><given-names>D</given-names></name><name name-style="western"><surname>Faria</surname><given-names>A</given-names></name><name name-style="western"><surname>Calhau</surname><given-names>C</given-names></name><name name-style="western"><surname>Azevedo</surname><given-names>I</given-names></name><name name-style="western"><surname>Monteiro</surname><given-names>R</given-names></name></person-group><article-title>Modulation of adipocyte biology by &#948;(9)-tetrahydrocannabinol</article-title><source>Obesity (Silver Spring, Md)</source><year>2010</year><volume>18</volume><issue>11</issue><fpage>2077</fpage><lpage>2085</lpage><pub-id pub-id-type="doi">10.1038/oby.2010.100</pub-id><pub-id pub-id-type="pmid">20467421</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="other">Chang RC, Thangavelu CS, Joloya EM, Kuo A, Li Z, Blumberg B. Cannabidiol promotes adipogenesis of human and mouse mesenchymal stem cells via PPAR&#947; by inducing lipogenesis but not lipolysis. Biochem Pharmacol. 2022;197:114910. 10.1016/j.bcp.2022.114910.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bcp.2022.114910</pub-id><pub-id pub-id-type="pmcid">PMC8917779</pub-id><pub-id pub-id-type="pmid">35026188</pub-id></mixed-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Desai</surname><given-names>M</given-names></name><name name-style="western"><surname>Beall</surname><given-names>M</given-names></name><name name-style="western"><surname>Ross</surname><given-names>MG</given-names></name></person-group><article-title>Developmental origins of obesity: programmed adipogenesis</article-title><source>Curr Diab Rep</source><year>2013</year><volume>13</volume><issue>1</issue><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1007/s11892-012-0344-x</pub-id><pub-id pub-id-type="pmid">23188593</pub-id><pub-id pub-id-type="pmcid">PMC3563293</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DiNieri</surname><given-names>JA</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Szutorisz</surname><given-names>H</given-names></name><name name-style="western"><surname>Spano</surname><given-names>SM</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>J</given-names></name><name name-style="western"><surname>Casaccia</surname><given-names>P</given-names></name><etal/></person-group><article-title>Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring</article-title><source>Biol Psychiat</source><year>2011</year><volume>70</volume><issue>8</issue><fpage>763</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2011.06.027</pub-id><pub-id pub-id-type="pmid">21820648</pub-id><pub-id pub-id-type="pmcid">PMC3186868</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="other">de Almeida DL, Devi LA. Diversity of molecular targets and signaling pathways for CBD. Pharmacol Res Perspect. 2020;8(6):e00682. 10.1002/prp2.682.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/prp2.682</pub-id><pub-id pub-id-type="pmcid">PMC7652785</pub-id><pub-id pub-id-type="pmid">33169541</pub-id></mixed-citation></ref><ref id="CR81"><label>81.</label><mixed-citation publication-type="other">Traccis F, Serra V, Sagheddu C, Congiu M, Saba P, Giua G,&#160;Devoto P, Frau R, Cheer JF, Melis M. Prenatal THC does not affect female mesolimbic dopaminergic system in preadolescent rats. Int J Mol Sci. 2021;22(4). 10.3390/ijms22041666.&#160;PMID: 33562259; PMCID: PMC7914408.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22041666</pub-id><pub-id pub-id-type="pmcid">PMC7914408</pub-id><pub-id pub-id-type="pmid">33562259</pub-id></mixed-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frau</surname><given-names>R</given-names></name><name name-style="western"><surname>Micz&#225;n</surname><given-names>V</given-names></name><name name-style="western"><surname>Traccis</surname><given-names>F</given-names></name><name name-style="western"><surname>Aroni</surname><given-names>S</given-names></name><name name-style="western"><surname>Pongor</surname><given-names>CI</given-names></name><name name-style="western"><surname>Saba</surname><given-names>P</given-names></name><etal/></person-group><article-title>Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone</article-title><source>Nat Neurosci</source><year>2019</year><volume>22</volume><issue>12</issue><fpage>1975</fpage><lpage>1985</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0512-2</pub-id><pub-id pub-id-type="pmid">31611707</pub-id><pub-id pub-id-type="pmcid">PMC6884689</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fern&#225;ndez-Ruiz</surname><given-names>J</given-names></name><name name-style="western"><surname>Berrendero</surname><given-names>F</given-names></name><name name-style="western"><surname>Hern&#225;ndez</surname><given-names>ML</given-names></name><name name-style="western"><surname>Ramos</surname><given-names>JA</given-names></name></person-group><article-title>The endogenous cannabinoid system and brain development</article-title><source>Trends Neurosci</source><year>2000</year><volume>23</volume><issue>1</issue><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/s0166-2236(99)01491-5</pub-id><pub-id pub-id-type="pmid">10631784</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossi</surname><given-names>F</given-names></name><name name-style="western"><surname>Punzo</surname><given-names>F</given-names></name><name name-style="western"><surname>Umano</surname><given-names>GR</given-names></name><name name-style="western"><surname>Argenziano</surname><given-names>M</given-names></name><name name-style="western"><surname>Miraglia Del Giudice</surname><given-names>E</given-names></name></person-group><article-title>Role of cannabinoids in obesity</article-title><source>Int J Mol Sci</source><year>2018</year><volume>19</volume><issue>9</issue><fpage>2690</fpage><pub-id pub-id-type="doi">10.3390/ijms19092690</pub-id><pub-id pub-id-type="pmid">30201891</pub-id><pub-id pub-id-type="pmcid">PMC6163475</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nogueiras</surname><given-names>R</given-names></name><name name-style="western"><surname>Rohner-Jeanrenaud</surname><given-names>F</given-names></name><name name-style="western"><surname>Woods</surname><given-names>SC</given-names></name><name name-style="western"><surname>Tsch&#246;p</surname><given-names>MH</given-names></name></person-group><article-title>The endocannabinoid system and the control of glucose homeostasis</article-title><source>J Neuroendocrinol</source><year>2008</year><volume>20</volume><issue>Suppl 1</issue><fpage>147</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2826.2008.01692.x</pub-id><pub-id pub-id-type="pmid">18426514</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berm&#250;dez-Silva</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Su&#225;rez</surname><given-names>J</given-names></name><name name-style="western"><surname>Baixeras</surname><given-names>E</given-names></name><name name-style="western"><surname>Cobo</surname><given-names>N</given-names></name><name name-style="western"><surname>Bautista</surname><given-names>D</given-names></name><name name-style="western"><surname>Cuesta-Mu&#241;oz</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Presence of functional cannabinoid receptors in human endocrine pancreas</article-title><source>Diabetologia</source><year>2008</year><volume>51</volume><issue>3</issue><fpage>476</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1007/s00125-007-0890-y</pub-id><pub-id pub-id-type="pmid">18092149</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malenczyk</surname><given-names>K</given-names></name><name name-style="western"><surname>Keimpema</surname><given-names>E</given-names></name><name name-style="western"><surname>Piscitelli</surname><given-names>F</given-names></name><name name-style="western"><surname>Calvigioni</surname><given-names>D</given-names></name><name name-style="western"><surname>Bj&#246;rklund</surname><given-names>P</given-names></name><name name-style="western"><surname>Mackie</surname><given-names>K</given-names></name><etal/></person-group><article-title>Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture</article-title><source>Proc Natl Acad Sci USA</source><year>2015</year><volume>112</volume><issue>45</issue><fpage>E6185</fpage><lpage>E6194</lpage><pub-id pub-id-type="doi">10.1073/pnas.1519040112</pub-id><pub-id pub-id-type="pmid">26494286</pub-id><pub-id pub-id-type="pmcid">PMC4653226</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klawitter</surname><given-names>J</given-names></name><name name-style="western"><surname>Sempio</surname><given-names>C</given-names></name><name name-style="western"><surname>Morlein</surname><given-names>S</given-names></name><name name-style="western"><surname>De Bloois</surname><given-names>E</given-names></name><name name-style="western"><surname>Klepacki</surname><given-names>J</given-names></name><name name-style="western"><surname>Henthorn</surname><given-names>T</given-names></name><etal/></person-group><article-title>An atmospheric pressure chemical ionization MS/MS assay using online extraction for the analysis of 11 cannabinoids and metabolites in human plasma and urine</article-title><source>Ther Drug Monit</source><year>2017</year><volume>39</volume><issue>5</issue><fpage>556</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1097/ftd.0000000000000427</pub-id><pub-id pub-id-type="pmid">28640062</pub-id><pub-id pub-id-type="pmcid">PMC5600652</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><mixed-citation publication-type="other">Selzer S, Morrison G, Bensadigh BM, Gelber K, Geller AW, Zakowski MI. Cannabidiol in pregnancy: attitudes of obstetric-related healthcare providers and women 18&#8211;44 years-old in California.</mixed-citation></ref><ref id="CR90"><label>90.</label><mixed-citation publication-type="other">De Genna NM, Kennon-McGill S, Goldschmidt L, Richardson GA, Chang JC. Factors associated with ever using cannabidiol in a cohort of younger pregnant people. Neurotoxicol Teratol. 2023;96:107162. 10.1016/j.ntt.2023.107162.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ntt.2023.107162</pub-id><pub-id pub-id-type="pmcid">PMC9992243</pub-id><pub-id pub-id-type="pmid">36717004</pub-id></mixed-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foltin</surname><given-names>RW</given-names></name><name name-style="western"><surname>Fischman</surname><given-names>MW</given-names></name><name name-style="western"><surname>Byrne</surname><given-names>MF</given-names></name></person-group><article-title>Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory</article-title><source>Appetite</source><year>1988</year><volume>11</volume><issue>1</issue><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/s0195-6663(88)80017-5</pub-id><pub-id pub-id-type="pmid">3228283</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pinto</surname><given-names>JS</given-names></name><name name-style="western"><surname>Martel</surname><given-names>F</given-names></name></person-group><article-title>Effects of cannabidiol on appetite and body weight: a systematic review</article-title><source>Clin Drug Investig</source><year>2022</year><volume>42</volume><issue>11</issue><fpage>909</fpage><lpage>919</lpage><pub-id pub-id-type="doi">10.1007/s40261-022-01205-y</pub-id><pub-id pub-id-type="pmid">36180814</pub-id><pub-id pub-id-type="pmcid">PMC9525229</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hollister</surname><given-names>LE</given-names></name><name name-style="western"><surname>Reaven</surname><given-names>GM</given-names></name></person-group><article-title>Delta-9-tetrahydrocannabinol and glucose tolerance</article-title><source>Clin Pharmacol Ther</source><year>1974</year><volume>16</volume><issue>2</issue><fpage>297</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1002/cpt1974162297</pub-id><pub-id pub-id-type="pmid">4851289</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>AB</given-names></name><name name-style="western"><surname>Cowen</surname><given-names>DL</given-names></name></person-group><article-title>Effect of intravenous injection of marihuana</article-title><source>JAMA</source><year>1969</year><volume>210</volume><issue>4</issue><fpage>724</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1001/jama.1969.03160300064021</pub-id><pub-id pub-id-type="pmid">5394409</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>JE</given-names></name><name name-style="western"><surname>Steahly</surname><given-names>LP</given-names></name><name name-style="western"><surname>Bier</surname><given-names>MM</given-names></name></person-group><article-title>Marihuana and the diabetic coma</article-title><source>JAMA</source><year>1970</year><volume>214</volume><issue>6</issue><fpage>1113</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1001/jama.1970.03180060087020</pub-id><pub-id pub-id-type="pmid">4990907</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><mixed-citation publication-type="other">Afshar S, Khalili S, Amin G, Abbasinazari M. A phase I randomized, double-blind, placebo-controlled study on efficacy and safety profile of a sublingually administered cannabidiol /delta 9-tetrahydrocannabidiol (10: 1) regimen in diabetes type 2 patients. Iran J Pharm Res. 2022;21(1):e132647. 10.5812/ijpr-132647.<pub-id pub-id-type="doi" assigning-authority="pmc">10.5812/ijpr-132647</pub-id><pub-id pub-id-type="pmcid">PMC10024807</pub-id><pub-id pub-id-type="pmid">36945340</pub-id></mixed-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jadoon</surname><given-names>KA</given-names></name><name name-style="western"><surname>Ratcliffe</surname><given-names>SH</given-names></name><name name-style="western"><surname>Barrett</surname><given-names>DA</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>EL</given-names></name><name name-style="western"><surname>Stott</surname><given-names>C</given-names></name><name name-style="western"><surname>Bell</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 Diabetes: a randomized, double-blind, placebo-controlled, parallel group pilot study</article-title><source>Diabetes Care</source><year>2016</year><volume>39</volume><issue>10</issue><fpage>1777</fpage><lpage>1786</lpage><pub-id pub-id-type="doi">10.2337/dc16-0650</pub-id><pub-id pub-id-type="pmid">27573936</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Symonds</surname><given-names>ME</given-names></name><name name-style="western"><surname>Pope</surname><given-names>M</given-names></name><name name-style="western"><surname>Sharkey</surname><given-names>D</given-names></name><name name-style="western"><surname>Budge</surname><given-names>H</given-names></name></person-group><article-title>Adipose tissue and fetal programming</article-title><source>Diabetologia</source><year>2012</year><volume>55</volume><issue>6</issue><fpage>1597</fpage><lpage>1606</lpage><pub-id pub-id-type="doi">10.1007/s00125-012-2505-5</pub-id><pub-id pub-id-type="pmid">22402988</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hines</surname><given-names>LA</given-names></name><name name-style="western"><surname>Spry</surname><given-names>EA</given-names></name><name name-style="western"><surname>Moreno-Betancur</surname><given-names>M</given-names></name><name name-style="western"><surname>Mohamad Husin</surname><given-names>H</given-names></name><name name-style="western"><surname>Becker</surname><given-names>D</given-names></name><name name-style="western"><surname>Middleton</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cannabis and tobacco use prior to pregnancy and subsequent offspring birth outcomes: a 20-year intergenerational prospective cohort study</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><issue>1</issue><fpage>16826</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-95460-2</pub-id><pub-id pub-id-type="pmid">34413325</pub-id><pub-id pub-id-type="pmcid">PMC8376878</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaforau</surname><given-names>LS</given-names></name><name name-style="western"><surname>Tessema</surname><given-names>GA</given-names></name><name name-style="western"><surname>Jancey</surname><given-names>J</given-names></name><name name-style="western"><surname>Bugoro</surname><given-names>H</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>G</given-names></name></person-group><article-title>Prevalence and factors associated with low birth weight in the Solomon Islands: evidence from the 2015 Solomon Islands demographic and Health survey data</article-title><source>Asia Pac J Public Health</source><year>2023</year><volume>35</volume><issue>2&#8211;3</issue><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1177/10105395231158868</pub-id><pub-id pub-id-type="pmid">36872610</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><mixed-citation publication-type="other">Misner MJ, Taborek A, Dufour J, Sharifi L, Khokhar JY, Favetta LA. Effects of delta-9 tetrahydrocannabinol (THC) on oocyte competence and early embryonic development. Front Toxicol. 2021;3:647918. 10.3389/ftox.2021.647918.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/ftox.2021.647918</pub-id><pub-id pub-id-type="pmcid">PMC8915882</pub-id><pub-id pub-id-type="pmid">35295104</pub-id></mixed-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>SK</given-names></name><name name-style="western"><surname>Itchon-Ramos</surname><given-names>N</given-names></name><name name-style="western"><surname>Visco</surname><given-names>Z</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Grenier</surname><given-names>C</given-names></name><name name-style="western"><surname>Schrott</surname><given-names>R</given-names></name><etal/></person-group><article-title>Cannabinoid exposure and altered DNA methylation in rat and human sperm</article-title><source>Epigenetics</source><year>2018</year><volume>13</volume><issue>12</issue><fpage>1208</fpage><lpage>1221</lpage><pub-id pub-id-type="doi">10.1080/15592294.2018.1554521</pub-id><pub-id pub-id-type="pmid">30521419</pub-id><pub-id pub-id-type="pmcid">PMC6986792</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><mixed-citation publication-type="other">Levin ED, Hawkey AB, Hall BJ, Cauley M, Slade S, Yazdani E, et al. Paternal THC exposure in rats causes long-lasting neurobehavioral effects in the offspring. Neurotoxicol Teratol. 2019;74:106806. 10.1016/j.ntt.2019.04.003.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ntt.2019.04.003</pub-id><pub-id pub-id-type="pmid">31028824</pub-id></mixed-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodwin</surname><given-names>RD</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Cheslack-Postava</surname><given-names>K</given-names></name><name name-style="western"><surname>Weinberger</surname><given-names>AH</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>Wyka</surname><given-names>K</given-names></name><etal/></person-group><article-title>Trends in cannabis use among adults with children in the home in the United States, 2004&#8211;2017: impact of state-level legalization for recreational and medical use</article-title><source>Addiction</source><year>2021</year><volume>116</volume><issue>10</issue><fpage>2770</fpage><lpage>2778</lpage><pub-id pub-id-type="doi">10.1111/add.15472</pub-id><pub-id pub-id-type="pmid">33730400</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>BF</given-names></name><name name-style="western"><surname>Salmons</surname><given-names>KA</given-names></name><name name-style="western"><surname>Hoyt</surname><given-names>AT</given-names></name><name name-style="western"><surname>Swenson</surname><given-names>KS</given-names></name><name name-style="western"><surname>Bates</surname><given-names>EA</given-names></name><name name-style="western"><surname>Sauder</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Associations between prenatal and postnatal exposure to cannabis with cognition and behavior at age 5 years: the Healthy Start Study</article-title><source>Int J Environ Res Public Health</source><year>2023</year><volume>20</volume><issue>6</issue><fpage>4880</fpage><pub-id pub-id-type="doi">10.3390/ijerph20064880</pub-id><pub-id pub-id-type="pmid">36981794</pub-id><pub-id pub-id-type="pmcid">PMC10049128</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>KM</given-names></name><name name-style="western"><surname>Torok</surname><given-names>MR</given-names></name><name name-style="western"><surname>Wei</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>M</given-names></name><name name-style="western"><surname>Sosnoff</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Detecting biomarkers of secondhand marijuana smoke in young children</article-title><source>Pediatr Res</source><year>2017</year><volume>81</volume><issue>4</issue><fpage>589</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1038/pr.2016.261</pub-id><pub-id pub-id-type="pmid">27911435</pub-id><pub-id pub-id-type="pmcid">PMC5701510</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sangmo</surname><given-names>L</given-names></name><name name-style="western"><surname>Braune</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Sosnoff</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Secondhand marijuana exposure in a convenience sample of young children in New York City</article-title><source>Pediatr Res</source><year>2021</year><volume>89</volume><issue>4</issue><fpage>905</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1038/s41390-020-0958-7</pub-id><pub-id pub-id-type="pmid">32403116</pub-id><pub-id pub-id-type="pmcid">PMC7882144</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sempio</surname><given-names>C</given-names></name><name name-style="western"><surname>Wymore</surname><given-names>E</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>C</given-names></name><name name-style="western"><surname>Bunik</surname><given-names>M</given-names></name><name name-style="western"><surname>Henthorn</surname><given-names>TK</given-names></name><name name-style="western"><surname>Christians</surname><given-names>U</given-names></name><etal/></person-group><article-title>Detection of cannabinoids by LC-MS-MS and ELISA in breast milk</article-title><source>J Anal Toxicol</source><year>2021</year><volume>45</volume><issue>7</issue><fpage>686</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1093/jat/bkaa142</pub-id><pub-id pub-id-type="pmid">33002141</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sempio</surname><given-names>C</given-names></name><name name-style="western"><surname>Lindley</surname><given-names>E</given-names></name><name name-style="western"><surname>Klawitter</surname><given-names>J</given-names></name><name name-style="western"><surname>Christians</surname><given-names>U</given-names></name><name name-style="western"><surname>Bowler</surname><given-names>RP</given-names></name><name name-style="western"><surname>Adgate</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Surface detection of THC attributable to vaporizer use in the indoor environment</article-title><source>Sci Rep</source><year>2019</year><volume>9</volume><issue>1</issue><fpage>18587</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-55151-5</pub-id><pub-id pub-id-type="pmid">31819131</pub-id><pub-id pub-id-type="pmcid">PMC6901575</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>J</given-names></name><name name-style="western"><surname>Zartarian</surname><given-names>V</given-names></name><name name-style="western"><surname>Moya</surname><given-names>J</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>N</given-names></name><name name-style="western"><surname>Beamer</surname><given-names>P</given-names></name><name name-style="western"><surname>Black</surname><given-names>K</given-names></name><etal/></person-group><article-title>A meta-analysis of children&#8217;s hand-to-mouth frequency data for estimating nondietary ingestion exposure</article-title><source>Risk Anal</source><year>2007</year><volume>27</volume><issue>2</issue><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1111/j.1539-6924.2007.00893.x</pub-id><pub-id pub-id-type="pmid">17511707</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fleming</surname><given-names>S</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>M</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>R</given-names></name><name name-style="western"><surname>Heneghan</surname><given-names>C</given-names></name><name name-style="western"><surname>Pl&#252;ddemann</surname><given-names>A</given-names></name><name name-style="western"><surname>Maconochie</surname><given-names>I</given-names></name><etal/></person-group><article-title>Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies</article-title><source>Lancet (London, England)</source><year>2011</year><volume>377</volume><issue>9770</issue><fpage>1011</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)62226-X</pub-id><pub-id pub-id-type="pmid">21411136</pub-id><pub-id pub-id-type="pmcid">PMC3789232</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohlsson</surname><given-names>A</given-names></name><name name-style="western"><surname>Lindgren</surname><given-names>JE</given-names></name><name name-style="western"><surname>Wahlen</surname><given-names>A</given-names></name><name name-style="western"><surname>Agurell</surname><given-names>S</given-names></name><name name-style="western"><surname>Hollister</surname><given-names>LE</given-names></name><name name-style="western"><surname>Gillespie</surname><given-names>HK</given-names></name></person-group><article-title>Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking</article-title><source>Clin Pharmacol Ther</source><year>1980</year><volume>28</volume><issue>3</issue><fpage>409</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1038/clpt.1980.181</pub-id><pub-id pub-id-type="pmid">6250760</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grotenhermen</surname><given-names>F</given-names></name></person-group><article-title>Pharmacokinetics and pharmacodynamics of cannabinoids</article-title><source>Clin Pharmacokinet</source><year>2003</year><volume>42</volume><issue>4</issue><fpage>327</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.2165/00003088-200342040-00003</pub-id><pub-id pub-id-type="pmid">12648025</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaston</surname><given-names>TE</given-names></name><name name-style="western"><surname>Friedman</surname><given-names>D</given-names></name></person-group><article-title>Pharmacology of cannabinoids in the treatment of epilepsy</article-title><source>Epilepsy Behav</source><year>2017</year><volume>70</volume><issue>Pt B</issue><fpage>313</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1016/j.yebeh.2016.11.016</pub-id><pub-id pub-id-type="pmid">28087250</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><mixed-citation publication-type="other">Young-Wolff KC, Adams SR, Wi S, Weisner C, Conway A. Routes of cannabis administration among females in the year before and during pregnancy: results from a pilot project. Addict Behav. 2020;100:106125. 10.1016/j.addbeh.2019.106125.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.addbeh.2019.106125</pub-id><pub-id pub-id-type="pmcid">PMC7945962</pub-id><pub-id pub-id-type="pmid">31600645</pub-id></mixed-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hatch</surname><given-names>EE</given-names></name><name name-style="western"><surname>Bracken</surname><given-names>MB</given-names></name></person-group><article-title>Effect of marijuana use in pregnancy on fetal growth</article-title><source>Am J Epidemiol</source><year>1986</year><volume>124</volume><issue>6</issue><fpage>986</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a114488</pub-id><pub-id pub-id-type="pmid">3776981</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Rosen</surname><given-names>TS</given-names></name><name name-style="western"><surname>Bateman</surname><given-names>D</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Legato</surname><given-names>MJ</given-names></name></person-group><article-title>Chapter 1 - the effects of gender in neonatal medicine</article-title><source>Principles of Gender-Specific Medicine</source><year>2010</year><edition>2</edition><publisher-loc>San Diego</publisher-loc><publisher-name>Academic Press</publisher-name><fpage>3</fpage><lpage>17</lpage></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broere-Brown</surname><given-names>ZA</given-names></name><name name-style="western"><surname>Baan</surname><given-names>E</given-names></name><name name-style="western"><surname>Schalekamp-Timmermans</surname><given-names>S</given-names></name><name name-style="western"><surname>Verburg</surname><given-names>BO</given-names></name><name name-style="western"><surname>Jaddoe</surname><given-names>VW</given-names></name><name name-style="western"><surname>Steegers</surname><given-names>EA</given-names></name></person-group><article-title>Sex-specific differences in fetal and infant growth patterns: a prospective population-based cohort study</article-title><source>Biol Sex Differ</source><year>2016</year><volume>7</volume><fpage>65</fpage><pub-id pub-id-type="doi">10.1186/s13293-016-0119-1</pub-id><pub-id pub-id-type="pmid">27980713</pub-id><pub-id pub-id-type="pmcid">PMC5135770</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Craft</surname><given-names>RM</given-names></name><name name-style="western"><surname>Marusich</surname><given-names>JA</given-names></name><name name-style="western"><surname>Wiley</surname><given-names>JL</given-names></name></person-group><article-title>Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?</article-title><source>Life Sci</source><year>2013</year><volume>92</volume><issue>8&#8211;9</issue><fpage>476</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2012.06.009</pub-id><pub-id pub-id-type="pmid">22728714</pub-id><pub-id pub-id-type="pmcid">PMC3492530</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeffery</surname><given-names>SC</given-names></name><name name-style="western"><surname>Hosking</surname><given-names>J</given-names></name><name name-style="western"><surname>Jeffery</surname><given-names>AN</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Voss</surname><given-names>LD</given-names></name><name name-style="western"><surname>Wilkin</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Insulin resistance is higher in prepubertal girls but switches to become higher in boys at age 16: a cohort study (EarlyBird 57)</article-title><source>Pediatr Diabetes</source><year>2018</year><volume>19</volume><issue>2</issue><fpage>223</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1111/pedi.12571</pub-id><pub-id pub-id-type="pmid">28851041</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pramfalk</surname><given-names>C</given-names></name><name name-style="western"><surname>Pavlides</surname><given-names>M</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>R</given-names></name><name name-style="western"><surname>McNeil</surname><given-names>CA</given-names></name><name name-style="western"><surname>Neubauer</surname><given-names>S</given-names></name><name name-style="western"><surname>Karpe</surname><given-names>F</given-names></name><etal/></person-group><article-title>Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher propensity for NAFLD in men</article-title><source>J Clin Endocrinol Metab</source><year>2015</year><volume>100</volume><issue>12</issue><fpage>4425</fpage><lpage>4433</lpage><pub-id pub-id-type="doi">10.1210/jc.2015-2649</pub-id><pub-id pub-id-type="pmid">26414963</pub-id><pub-id pub-id-type="pmcid">PMC4667166</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tran</surname><given-names>C</given-names></name><name name-style="western"><surname>Jacot-Descombes</surname><given-names>D</given-names></name><name name-style="western"><surname>Lecoultre</surname><given-names>V</given-names></name><name name-style="western"><surname>Fielding</surname><given-names>BA</given-names></name><name name-style="western"><surname>Carrel</surname><given-names>G</given-names></name><name name-style="western"><surname>L&#234;</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Sex differences in lipid and glucose kinetics after ingestion of an acute oral fructose load</article-title><source>Br J Nutr</source><year>2010</year><volume>104</volume><issue>8</issue><fpage>1139</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1017/s000711451000190x</pub-id><pub-id pub-id-type="pmid">20540820</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agrawal</surname><given-names>A</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>CE</given-names></name><name name-style="western"><surname>Lessov-Schlaggar</surname><given-names>CN</given-names></name><name name-style="western"><surname>Carter</surname><given-names>EB</given-names></name><name name-style="western"><surname>Lenze</surname><given-names>SN</given-names></name><name name-style="western"><surname>Grucza</surname><given-names>RA</given-names></name></person-group><article-title>Alcohol, cigarette, and cannabis use between 2002 and 2016 in pregnant women from a nationally representative sample</article-title><source>JAMA Pediatr</source><year>2019</year><volume>173</volume><issue>1</issue><fpage>95</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1001/jamapediatrics.2018.3096</pub-id><pub-id pub-id-type="pmid">30398527</pub-id><pub-id pub-id-type="pmcid">PMC6500767</pub-id></element-citation></ref></ref-list></ref-list></back></article></pmc-articleset>